<html class="gs_el_sm gs_pfcs"><head><title>‪Dyfrig Hughes‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.com/citations?user=_q2u5IIAAAAJ&amp;hl=en"><meta name="description" content="‪Professor of pharmacoeconomics,  Bangor University‬ - ‪‪Cited by 9,972‬‬ - ‪Pharmacoeconomics‬ - ‪health technology assessment‬ - ‪pharmacogenetics‬ - ‪medication adherence‬ - ‪pharmaceutical policy‬"><meta property="og:description" content="‪Professor of pharmacoeconomics,  Bangor University‬ - ‪‪Cited by 9,972‬‬ - ‪Pharmacoeconomics‬ - ‪health technology assessment‬ - ‪pharmacogenetics‬ - ‪medication adherence‬ - ‪pharmaceutical policy‬"><meta property="og:title" content="Dyfrig Hughes"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=_q2u5IIAAAAJ&amp;citpid=1"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"UjUzYeaMG4qrmwHK3IKACA"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=_q2u5IIAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=_q2u5IIAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=_q2u5IIAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=_q2u5IIAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYTSG0iRGB0ZoVxsrvX2FSK0Oa5ali1F_"><input type="hidden" name="user" value="_q2u5IIAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">9972</td><td class="gsc_rsb_std">6293</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">48</td><td class="gsc_rsb_std">41</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">135</td><td class="gsc_rsb_std">104</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:642px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:600px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">1300</div><div class="gsc_g_xtl" style="top:73px;">650</div><div class="gsc_g_xtl" style="top:113px;">325</div><div class="gsc_g_xtl" style="top:33px;">975</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:156px;height:4px;z-index:18"><span class="gsc_g_al">33</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:155px;height:5px;z-index:17"><span class="gsc_g_al">47</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:146px;height:14px;z-index:16"><span class="gsc_g_al">115</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:146px;height:14px;z-index:15"><span class="gsc_g_al">117</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:145px;height:15px;z-index:14"><span class="gsc_g_al">129</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:140px;height:20px;z-index:13"><span class="gsc_g_al">168</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:126px;height:34px;z-index:12"><span class="gsc_g_al">284</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:126px;height:34px;z-index:11"><span class="gsc_g_al">284</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:105px;height:55px;z-index:10"><span class="gsc_g_al">454</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:99px;height:61px;z-index:9"><span class="gsc_g_al">501</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:83px;height:77px;z-index:8"><span class="gsc_g_al">631</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:74px;height:86px;z-index:7"><span class="gsc_g_al">706</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:60px;height:100px;z-index:6"><span class="gsc_g_al">819</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:33px;height:127px;z-index:5"><span class="gsc_g_al">1032</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:30px;height:130px;z-index:4"><span class="gsc_g_al">1061</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:17px;height:143px;z-index:3"><span class="gsc_g_al">1163</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:12px;height:148px;z-index:2"><span class="gsc_g_al">1210</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:40px;height:120px;z-index:1"><span class="gsc_g_al">981</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=_q2u5IIAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3d_q2u5IIAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>86 articles</span></div><div class="gsc_rsb_m_na"><div>4 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:4%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_co" role="region" aria-labelledby="gsc_prf_t-ath"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Co-authors</span></h3><ul class="gsc_rsb_a"><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-AY59qbYAAAAJ-img{width:24px;height:32px;}.gs_el_ta #gsc_rsb-AY59qbYAAAAJ-img,.gs_el_ph #gsc_rsb-AY59qbYAAAAJ-img{width:42px;height:56px;}</style><span id="gsc_rsb-AY59qbYAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Munir Pirmohamed" sizes="(max-width:981px) 42px,24px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=AY59qbYAAAAJ&amp;citpid=2" id="gsc_rsb-AY59qbYAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=AY59qbYAAAAJ&amp;citpid=2 24w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=AY59qbYAAAAJ&amp;citpid=2 42w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=AY59qbYAAAAJ&amp;citpid=2 96w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=AY59qbYAAAAJ&amp;hl=en">Munir Pirmohamed</a><span class="gsc_rsb_a_ext">University of Liverpool</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at liv.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-ZeiXBwMAAAAJ-img{width:21px;height:32px;}.gs_el_ta #gsc_rsb-ZeiXBwMAAAAJ-img,.gs_el_ph #gsc_rsb-ZeiXBwMAAAAJ-img{width:37px;height:56px;}</style><span id="gsc_rsb-ZeiXBwMAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Emily Fargher Holmes" sizes="(max-width:981px) 37px,21px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=ZeiXBwMAAAAJ&amp;citpid=3" id="gsc_rsb-ZeiXBwMAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=ZeiXBwMAAAAJ&amp;citpid=3 21w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=ZeiXBwMAAAAJ&amp;citpid=3 37w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=ZeiXBwMAAAAJ&amp;citpid=3 85w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=ZeiXBwMAAAAJ&amp;hl=en">Emily Fargher Holmes</a><span class="gsc_rsb_a_ext">Research Fellow, Bangor University</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at bangor.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-iGncw40AAAAJ-img{width:32px;height:32px;}.gs_el_ta #gsc_rsb-iGncw40AAAAJ-img,.gs_el_ph #gsc_rsb-iGncw40AAAAJ-img{width:56px;height:56px;}</style><span id="gsc_rsb-iGncw40AAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Catrin Plumpton" sizes="(max-width:981px) 56px,32px" src="/citations/images/avatar_scholar_56.png" id="gsc_rsb-iGncw40AAAAJ-img" class="gs_pp_df" srcset="/citations/images/avatar_scholar_32.png 32w,/citations/images/avatar_scholar_56.png 56w,/citations/images/avatar_scholar_128.png 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=iGncw40AAAAJ&amp;hl=en">Catrin Plumpton</a><span class="gsc_rsb_a_ext">Bangor University</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at bangor.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-i2bVNHsAAAAJ-img{width:21px;height:32px;}.gs_el_ta #gsc_rsb-i2bVNHsAAAAJ-img,.gs_el_ph #gsc_rsb-i2bVNHsAAAAJ-img{width:37px;height:56px;}</style><span id="gsc_rsb-i2bVNHsAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Bernard Vrijens" sizes="(max-width:981px) 37px,21px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=i2bVNHsAAAAJ&amp;citpid=2" id="gsc_rsb-i2bVNHsAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=i2bVNHsAAAAJ&amp;citpid=2 21w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=i2bVNHsAAAAJ&amp;citpid=2 37w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=i2bVNHsAAAAJ&amp;citpid=2 85w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=i2bVNHsAAAAJ&amp;hl=en">Bernard Vrijens</a><span class="gsc_rsb_a_ext">AARDEX Group and Liège University, Belgium</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at aardexgroup.com</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-QHuOXzUAAAAJ-img{width:32px;height:32px;}.gs_el_ta #gsc_rsb-QHuOXzUAAAAJ-img,.gs_el_ph #gsc_rsb-QHuOXzUAAAAJ-img{width:56px;height:56px;}</style><span id="gsc_rsb-QHuOXzUAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Sabina De Geest" sizes="(max-width:981px) 56px,32px" src="/citations/images/avatar_scholar_56.png" id="gsc_rsb-QHuOXzUAAAAJ-img" class="gs_pp_df" srcset="/citations/images/avatar_scholar_32.png 32w,/citations/images/avatar_scholar_56.png 56w,/citations/images/avatar_scholar_128.png 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=QHuOXzUAAAAJ&amp;hl=en">Sabina De Geest</a><span class="gsc_rsb_a_ext">Professor University of Basel (CH) &amp; KU Leuven (B)</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at unibas.ch</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-_0kV19AAAAAJ-img{width:32px;height:21px;}.gs_el_ta #gsc_rsb-_0kV19AAAAAJ-img,.gs_el_ph #gsc_rsb-_0kV19AAAAAJ-img{width:56px;height:37px;}</style><span id="gsc_rsb-_0kV19AAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Ian Russell" sizes="(max-width:981px) 56px,32px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=_0kV19AAAAAJ&amp;citpid=2" id="gsc_rsb-_0kV19AAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=_0kV19AAAAAJ&amp;citpid=2 32w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=_0kV19AAAAAJ&amp;citpid=2 56w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=_0kV19AAAAAJ&amp;citpid=2 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=_0kV19AAAAAJ&amp;hl=en">Ian Russell</a><span class="gsc_rsb_a_ext">Professor of Clinical Trials, Swansea University</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at swansea.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-HJD64R0AAAAJ-img{width:32px;height:24px;}.gs_el_ta #gsc_rsb-HJD64R0AAAAJ-img,.gs_el_ph #gsc_rsb-HJD64R0AAAAJ-img{width:56px;height:42px;}</style><span id="gsc_rsb-HJD64R0AAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Paula R Williamson" sizes="(max-width:981px) 56px,32px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=HJD64R0AAAAJ&amp;citpid=2" id="gsc_rsb-HJD64R0AAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=HJD64R0AAAAJ&amp;citpid=2 32w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=HJD64R0AAAAJ&amp;citpid=2 56w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=HJD64R0AAAAJ&amp;citpid=2 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=HJD64R0AAAAJ&amp;hl=en">Paula R Williamson</a><span class="gsc_rsb_a_ext"></span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at liv.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-ZBv4q8IAAAAJ-img{width:21px;height:32px;}.gs_el_ta #gsc_rsb-ZBv4q8IAAAAJ-img,.gs_el_ph #gsc_rsb-ZBv4q8IAAAAJ-img{width:37px;height:56px;}</style><span id="gsc_rsb-ZBv4q8IAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Carrol Gamble" sizes="(max-width:981px) 37px,21px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=ZBv4q8IAAAAJ&amp;citpid=4" id="gsc_rsb-ZBv4q8IAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=ZBv4q8IAAAAJ&amp;citpid=4 21w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=ZBv4q8IAAAAJ&amp;citpid=4 37w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=ZBv4q8IAAAAJ&amp;citpid=4 85w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=ZBv4q8IAAAAJ&amp;hl=en">Carrol Gamble</a><span class="gsc_rsb_a_ext">Professor of Medical Statistics, University of Liverpool</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at liverpool.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-qugGPlMAAAAJ-img{width:24px;height:32px;}.gs_el_ta #gsc_rsb-qugGPlMAAAAJ-img,.gs_el_ph #gsc_rsb-qugGPlMAAAAJ-img{width:42px;height:56px;}</style><span id="gsc_rsb-qugGPlMAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Nefyn Williams" sizes="(max-width:981px) 42px,24px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=qugGPlMAAAAJ&amp;citpid=1" id="gsc_rsb-qugGPlMAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=qugGPlMAAAAJ&amp;citpid=1 24w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=qugGPlMAAAAJ&amp;citpid=1 42w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=qugGPlMAAAAJ&amp;citpid=1 96w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=qugGPlMAAAAJ&amp;hl=en">Nefyn Williams</a><span class="gsc_rsb_a_ext">Professor in Primary Care, University of Liverpool</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at liverpool.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-QIEQZ7IAAAAJ-img{width:24px;height:32px;}.gs_el_ta #gsc_rsb-QIEQZ7IAAAAJ-img,.gs_el_ph #gsc_rsb-QIEQZ7IAAAAJ-img{width:42px;height:56px;}</style><span id="gsc_rsb-QIEQZ7IAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="J K Aronson" sizes="(max-width:981px) 42px,24px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=QIEQZ7IAAAAJ&amp;citpid=2" id="gsc_rsb-QIEQZ7IAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=QIEQZ7IAAAAJ&amp;citpid=2 24w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=QIEQZ7IAAAAJ&amp;citpid=2 42w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=QIEQZ7IAAAAJ&amp;citpid=2 95w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=QIEQZ7IAAAAJ&amp;hl=en">J K Aronson</a><span class="gsc_rsb_a_ext">University of Oxford</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at phc.ox.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-x6wJwQsAAAAJ-img{width:32px;height:21px;}.gs_el_ta #gsc_rsb-x6wJwQsAAAAJ-img,.gs_el_ph #gsc_rsb-x6wJwQsAAAAJ-img{width:56px;height:37px;}</style><span id="gsc_rsb-x6wJwQsAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="A V Ramanan" sizes="(max-width:981px) 56px,32px" src="https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=x6wJwQsAAAAJ&amp;citpid=4" id="gsc_rsb-x6wJwQsAAAAJ-img" class="gs_pp_df" srcset="https://scholar.googleusercontent.com/citations?view_op=tiny_photo&amp;user=x6wJwQsAAAAJ&amp;citpid=4 32w,https://scholar.googleusercontent.com/citations?view_op=small_photo&amp;user=x6wJwQsAAAAJ&amp;citpid=4 56w,https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=x6wJwQsAAAAJ&amp;citpid=4 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=x6wJwQsAAAAJ&amp;hl=en">A V Ramanan</a><span class="gsc_rsb_a_ext">University Hospitals Bristol NHS Trust/University of Bristol</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at bristol.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li><li><div class="gsc_rsb_aa" tabindex="0"><style>#gsc_rsb-IZ3yTVcAAAAJ-img{width:32px;height:32px;}.gs_el_ta #gsc_rsb-IZ3yTVcAAAAJ-img,.gs_el_ph #gsc_rsb-IZ3yTVcAAAAJ-img{width:56px;height:56px;}</style><span id="gsc_rsb-IZ3yTVcAAAAJ" class="gs_rimg gs_pp_tn gs_pp_mo_sm gsc_rsb_a_pht"><img alt="Ana Alfirevic" sizes="(max-width:981px) 56px,32px" src="/citations/images/avatar_scholar_56.png" id="gsc_rsb-IZ3yTVcAAAAJ-img" class="gs_pp_df" srcset="/citations/images/avatar_scholar_32.png 32w,/citations/images/avatar_scholar_56.png 56w,/citations/images/avatar_scholar_128.png 128w"></span><span class="gsc_rsb_a_desc"><a tabindex="-1" href="/citations?user=IZ3yTVcAAAAJ&amp;hl=en">Ana Alfirevic</a><span class="gsc_rsb_a_ext">University of Liverpool</span><span class="gsc_rsb_a_ext gsc_rsb_a_ext2">Verified email at liv.ac.uk</span><span class="gsc_rsb_tap"><span class="gs_btnPR"><span class="gs_ico"></span></span></span></span></div></li></ul></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:80pt;}}</style><img alt="Dyfrig Hughes" sizes="print 80px,128px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=_q2u5IIAAAAJ&amp;citpid=1" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=_q2u5IIAAAAJ&amp;citpid=1 128w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=_q2u5IIAAAAJ&amp;citpid=1 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Dyfrig Hughes</div><div class="gsc_prf_il">Professor of pharmacoeconomics,  <a href="/citations?view_op=view_org&amp;hl=en&amp;org=1405071098375703846" class="gsc_prf_ila">Bangor University</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at bangor.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:pharmacoeconomics" class="gsc_prf_inta gs_ibl">Pharmacoeconomics</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:health_technology_assessment" class="gsc_prf_inta gs_ibl">health technology assessment</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:pharmacogenetics" class="gsc_prf_inta gs_ibl">pharmacogenetics</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:medication_adherence" class="gsc_prf_inta gs_ibl">medication adherence</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:pharmaceutical_policy" class="gsc_prf_inta gs_ibl">pharmaceutical policy</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a><a id="gsc_prf_t-ath" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_co">Co-authors</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=_q2u5IIAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYTSG0iRGB0ZoVxsrvX2FSK0Oa5ali1F_"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=_q2u5IIAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=_q2u5IIAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=_q2u5IIAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=_q2u5IIAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=_q2u5IIAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">A new taxonomy for describing and defining adherence to medications</a><div class="gs_gray">B Vrijens, S De Geest, DA Hughes, K Przemyslaw, J Demonceau, ...</div><div class="gs_gray">British journal of clinical pharmacology 73 (5), 691-705<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10784671351359133004" class="gsc_a_ac gs_ibl">1319</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:_B80troHkn4C" class="gsc_a_at">Is exercise effective in promoting mental well-being in older age? A systematic review</a><div class="gs_gray">G Windle, D Hughes, P Linck, I Russell, B Woods</div><div class="gs_gray">Aging &amp; mental health 14 (6), 652-669<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7243338881886877089" class="gsc_a_ac gs_ibl">318</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">Cost-effectiveness analysis of HLA B* 5701 genotyping in preventing abacavir hypersensitivity</a><div class="gs_gray">DA Hughes, FJ Vilar, CC Ward, A Alfirevic, BK Park, M Pirmohamed</div><div class="gs_gray">Pharmacogenetics and Genomics 14 (6), 335-342<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10455991899961365997" class="gsc_a_ac gs_ibl">311</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:_axFR9aDTf0C" class="gsc_a_at">Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic&nbsp;…</a><div class="gs_gray">J Demonceau, T Ruppar, P Kristanto, DA Hughes, E Fargher, P Kardas, ...</div><div class="gs_gray">Drugs 73 (6), 545-562<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11265118173033494200" class="gsc_a_ac gs_ibl">286</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:u-coK7KVo8oC" class="gsc_a_at">Drugs for exceptionally rare diseases: do they deserve special status for funding?</a><div class="gs_gray">DA Hughes, B Tunnage, ST Yeo</div><div class="gs_gray">Qjm 98 (11), 829-836<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13584612836930869676" class="gsc_a_ac gs_ibl">242</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis</a><div class="gs_gray">RT Edwards, A Céilleachair, T Bywater, DA Hughes, J Hutchings</div><div class="gs_gray">Bmj 334 (7595), 682<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5522153950955295410" class="gsc_a_ac gs_ibl">237</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis</a><div class="gs_gray">AV Ramanan, AD Dick, AP Jones, A McKay, PR Williamson, ...</div><div class="gs_gray">New England Journal of Medicine 376 (17), 1637-1646<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5353934691349493006" class="gsc_a_ac gs_ibl">228</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature</a><div class="gs_gray">DA Hughes, A Bagust, A Haycox, T Walley</div><div class="gs_gray">Health economics 10 (7), 601-615<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=587887482459514434" class="gsc_a_ac gs_ibl">228</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:OTTXONDVkokC" class="gsc_a_at">Non-compliance with antibiotic therapy for acute community infections: a global survey</a><div class="gs_gray">JC Pechère, D Hughes, P Kardas, G Cornaglia</div><div class="gs_gray">International journal of antimicrobial agents 29 (3), 245-253<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12414078758871350562" class="gsc_a_ac gs_ibl">226</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses</a><div class="gs_gray">J Pink, S Lane, M Pirmohamed, DA Hughes</div><div class="gs_gray">Bmj 343<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=356989394625907094" class="gsc_a_ac gs_ibl">215</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:4hFrxpcac9AC" class="gsc_a_at">Rare disease terminology and definitions—a systematic global review: report of the ISPOR rare disease special interest group</a><div class="gs_gray">T Richter, S Nestler-Parr, R Babela, ZM Khan, T Tesoro, E Molsen, ...</div><div class="gs_gray">Value in health 18 (6), 906-914<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12163664588461909579" class="gsc_a_ac gs_ibl">205</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Societal views on NICE, cancer drugs fund and value‐based pricing criteria for prioritising medicines: A cross‐sectional survey of 4118 adults in Great Britain</a><div class="gs_gray">WG Linley, DA Hughes</div><div class="gs_gray">Health economics 22 (8), 948-964<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6848669562067840075" class="gsc_a_ac gs_ibl">200</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:J-pR_7NvFogC" class="gsc_a_at">Nurse‐led vs. conventional physician‐led follow‐up for patients with cancer: systematic review</a><div class="gs_gray">R Lewis, RD Neal, NH Williams, B France, C Wilkinson, M Hendry, ...</div><div class="gs_gray">Journal of advanced nursing 65 (4), 706-723<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6544833605378279921" class="gsc_a_ac gs_ibl">196</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:-FonjvnnhkoC" class="gsc_a_at">Generic and therapeutic substitutions in the UK: are they a good thing?</a><div class="gs_gray">MG Duerden, DA Hughes</div><div class="gs_gray">British journal of clinical pharmacology 70 (3), 335-341<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10445808790049851003" class="gsc_a_ac gs_ibl">185</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and&nbsp;…</a><div class="gs_gray">FH Gwadry-Sridhar, E Manias, L Lal, M Salas, DA Hughes, ...</div><div class="gs_gray">Value in Health 16 (5), 863-871<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9965503027166655438" class="gsc_a_ac gs_ibl">167</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:48xauSegjOkC" class="gsc_a_at">ESPACOMP medication adherence reporting guideline (EMERGE)</a><div class="gs_gray">S De Geest, LL Zullig, J Dunbar-Jacob, R Helmy, DA Hughes, IB Wilson, ...</div><div class="gs_gray">Annals of internal medicine 169 (1), 30-35<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15209523242734190192,1000422124379368194" class="gsc_a_ac gs_ibl">156</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:f2IySw72cVMC" class="gsc_a_at">Follow-up of cancer in primary care versus secondary care: systematic review</a><div class="gs_gray">RA Lewis, RD Neal, NH Williams, B France, M Hendry, D Russell, ...</div><div class="gs_gray">British Journal of General Practice 59 (564), e234-e247<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4462643926572121751" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature</a><div class="gs_gray">M Salas, D Hughes, A Zuluaga, K Vardeva, M Lebmeier</div><div class="gs_gray">Value in Health 12 (6), 915-922<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4133453784053194057" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Patients' and healthcare professionals' views of cancer follow-up: systematic review</a><div class="gs_gray">RA Lewis, RD Neal, M Hendry, B France, NH Williams, D Russell, ...</div><div class="gs_gray">British Journal of General Practice 59 (564), e248-e259<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7727290097852882982" class="gsc_a_ac gs_ibl">135</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;citation_for_view=_q2u5IIAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Cost‐effectiveness of biological therapy for Crohn’s disease: Markov cohort analyses incorporating United Kingdom patient‐level cost data</a><div class="gs_gray">K Bodger, T Kikuchi, D Hughes</div><div class="gs_gray">Alimentary pharmacology &amp; therapeutics 30 (3), 265-274<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6091116760492488608" class="gsc_a_ac gs_ibl">131</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">The ROAM/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial</a><div class="gs_gray">MD Jenkinson, M Javadpour, BJ Haylock, B Young, H Gillard, J Vinten, ...</div><div class="gs_gray">Trials 16 (1), 1-8<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8732932604277472228" class="gsc_a_ac gs_ibl">126</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:7wO8s98CvbsC" class="gsc_a_at">Predicting adherence to medications using health psychology theories: a systematic review of 20 years of empirical research</a><div class="gs_gray">EAF Holmes, DA Hughes, VL Morrison</div><div class="gs_gray">Value in Health 17 (8), 863-876<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15784177791289727826" class="gsc_a_ac gs_ibl">126</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Challenges in the development and reimbursement of personalized medicine—payer and manufacturer perspectives and implications for health economics and outcomes research: a&nbsp;…</a><div class="gs_gray">E Faulkner, L Annemans, L Garrison, M Helfand, AP Holtorf, J Hornberger, ...</div><div class="gs_gray">Value in Health 15 (8), 1162-1171<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16350404129692640376" class="gsc_a_ac gs_ibl">122</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations</a><div class="gs_gray">D Hughes, W Cowell, T Koncz, J Cramer</div><div class="gs_gray">Value in health 10 (6), 498-509<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11071157138649842283" class="gsc_a_ac gs_ibl">115</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:wKETBy42zhYC" class="gsc_a_at">Accounting for noncompliance in pharmacoeconomic evaluations</a><div class="gs_gray">DA Hughes, A Bagust, A Haycox, T Walley</div><div class="gs_gray">Pharmacoeconomics 19 (12), 1185-1197<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16076953268033875833" class="gsc_a_ac gs_ibl">108</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">A systematic review of economic evaluations of pharmacogenetic testing for prevention of adverse drug reactions</a><div class="gs_gray">CO Plumpton, D Roberts, M Pirmohamed, DA Hughes</div><div class="gs_gray">Pharmacoeconomics 34 (8), 771-793<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6473460170519994671" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:AXkvAH5U_nMC" class="gsc_a_at">The population pharmacokinetics of <i>R</i>‐ and <i>S</i>‐warfarin: effect of genetic and clinical factors</a><div class="gs_gray">S Lane, S Al‐Zubiedi, E Hatch, I Matthews, AL Jorgensen, P Deloukas, ...</div><div class="gs_gray">British journal of clinical pharmacology 73 (1), 66-76<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16944178545096178457" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile&nbsp;…</a><div class="gs_gray">AV Ramanan, AD Dick, D Benton, S Compeyrot-Lacassagne, D Dawoud, ...</div><div class="gs_gray">Trials 15 (1), 1-13<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1811597820066595910" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Methods for the collection of resource use data within clinical trials: a systematic review of studies funded by the UK Health Technology Assessment program</a><div class="gs_gray">CH Ridyard, DA Hughes</div><div class="gs_gray">Value in Health 13 (8), 867-872<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14057296817562197904" class="gsc_a_ac gs_ibl">90</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">Understanding medication compliance and persistence from an economics perspective</a><div class="gs_gray">RA Elliott, JA Shinogle, P Peele, M Bhosle, DA Hughes</div><div class="gs_gray">Value in health 11 (4), 600-610<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16672862321116674057" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:3htObqc8RwsC" class="gsc_a_at">Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial</a><div class="gs_gray">RE Gilbert, Q Mok, K Dwan, K Harron, T Moitt, M Millar, P Ramnarayan, ...</div><div class="gs_gray">The Lancet 387 (10029), 1732-1742<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12969179539790181402" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Predictors of self-reported adherence to antihypertensive medicines: a multinational, cross-sectional survey</a><div class="gs_gray">VL Morrison, EAF Holmes, S Parveen, CO Plumpton, W Clyne, ...</div><div class="gs_gray">Value in Health 18 (2), 206-216<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16299174852669466199" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence &amp; Persistence Special&nbsp;…</a><div class="gs_gray">M Hiligsmann, M Salas, DA Hughes, E Manias, FH Gwadry-Sridhar, ...</div><div class="gs_gray">Osteoporosis international 24 (12), 2907-2918<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12302118005004078653" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study</a><div class="gs_gray">AL Jorgensen, S Al-Zubiedi, JE Zhang, A Keniry, A Hanson, DA Hughes, ...</div><div class="gs_gray">Pharmacogenetics and genomics 19 (10), 800<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15593510350657900648" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">A global survey of antibiotic leftovers in the outpatient setting</a><div class="gs_gray">P Kardas, JC Pechère, DA Hughes, G Cornaglia</div><div class="gs_gray">International journal of antimicrobial agents 30 (6), 530-536<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=440384216018353025" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:L1USKYWJimsC" class="gsc_a_at">An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2&nbsp;…</a><div class="gs_gray">A Farmer, W Hardeman, D Hughes, AT Prevost, Y Kim, A Craven, J Oke, ...</div><div class="gs_gray">BMC family practice 13 (1), 1-9<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16195710994680494395" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Cost‐effectiveness of pharmacogenetics‐guided warfarin therapy vs. alternative anticoagulation in atrial fibrillation</a><div class="gs_gray">J Pink, M Pirmohamed, S Lane, DA Hughes</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 95 (2), 199-207<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5745618898071286345" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity</a><div class="gs_gray">S Sutton, AL Kinmonth, W Hardeman, D Hughes, S Boase, AT Prevost, ...</div><div class="gs_gray">Annals of Behavioral Medicine 48 (3), 293-299<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2624219535856209177" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Resource-use measurement based on patient recall: issues and challenges for economic evaluation</a><div class="gs_gray">JC Thorn, J Coast, D Cohen, W Hollingworth, M Knapp, SM Noble, ...</div><div class="gs_gray">Applied health economics and health policy 11 (3), 155-161<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13903842523184827548" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">The development of a QALY measure for epilepsy: NEWQOL-6D</a><div class="gs_gray">B Mulhern, D Rowen, A Jacoby, T Marson, D Snape, D Hughes, N Latimer, ...</div><div class="gs_gray">Epilepsy &amp; Behavior 24 (1), 36-43<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1844679627055054547" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:ALROH1vI_8AC" class="gsc_a_at">Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of&nbsp;…</a><div class="gs_gray">DJ Bell, D Wootton, M Mukaka, J Montgomery, N Kayange, P Chimpeni, ...</div><div class="gs_gray">Malaria journal 8 (1), 1-11<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15231409837454823371" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Development of a database of instruments for resource-use measurement: purpose, feasibility, and design</a><div class="gs_gray">CH Ridyard, DA Hughes, DIRUM Team</div><div class="gs_gray">Value in Health 15 (5), 650-655<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4579203667677122883" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:prdVHNxh-e8C" class="gsc_a_at">New drugs for old: disinvestment and NICE</a><div class="gs_gray">DA Hughes, RE Ferner</div><div class="gs_gray">Bmj 340<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16322306047658533314" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">Defining rewardable innovation in drug therapy</a><div class="gs_gray">JK Aronson, RE Ferner, DA Hughes</div><div class="gs_gray">Nature reviews Drug discovery 11 (4), 253-254<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12055088072923373566" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">Cost‐effectiveness of screening for <i>HLA‐A*31:01</i> prior to initiation of carbamazepine in epilepsy</a><div class="gs_gray">CO Plumpton, VLM Yip, A Alfirevic, AG Marson, M Pirmohamed, ...</div><div class="gs_gray">Epilepsia 56 (4), 556-563<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12474970346325174798" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:0N-VGjzr574C" class="gsc_a_at">The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol</a><div class="gs_gray">MD Jenkinson, C Gamble, JC Hartley, H Hickey, D Hughes, M Blundell, ...</div><div class="gs_gray">Trials 15 (1), 1-7<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10930565737434403391" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:qUcmZB5y_30C" class="gsc_a_at">When drugs don’t work</a><div class="gs_gray">D Hughes</div><div class="gs_gray">Pharmacoeconomics 25 (8), 621-635<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2232496996040666491" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:WC23djZS0W4C" class="gsc_a_at">Multiple imputation of multiple multi-item scales when a full imputation model is infeasible</a><div class="gs_gray">CO Plumpton, T Morris, DA Hughes, IR White</div><div class="gs_gray">BMC research notes 9 (1), 1-15<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15805824035352183526" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Folate Augmentation of Treatment--Evaluation for Depression (FolATED): randomised trial and economic evaluation.</a><div class="gs_gray">E Bedson, D Bell, D Carr, B Carter, D Hughes, A Jorgensen, H Lewis, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 18 (48), vii<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17255696854443563768" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Current assessment of risk–benefit by regulators: is it time to introduce decision analyses?</a><div class="gs_gray">DA Hughes, AM Bayoumi, M Pirmohamed</div><div class="gs_gray">Clinical pharmacology &amp; therapeutics 82 (2), 123-127<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9466843031356958821" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:roLk4NBRz8UC" class="gsc_a_at">NICE and new: appraising innovation</a><div class="gs_gray">RE Ferner, DA Hughes, JK Aronson</div><div class="gs_gray">Bmj 340<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=601503017847073350" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Clinical Pharmacology</a><div class="gs_gray">KN Atuah, D Hughes, M Pirmohamed</div><div class="gs_gray">Drug safety 27 (8), 535-554<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16908558093804544947" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Economic evaluations during early (Phase II) drug development</a><div class="gs_gray">DA Hughes, T Walley</div><div class="gs_gray">Pharmacoeconomics 19 (11), 1069-1077<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1577556419296535416" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">A framework for planning and critiquing medication compliance and persistence research using prospective study designs</a><div class="gs_gray">FH Gwadry-Sridhar, E Manias, Y Zhang, A Roy, K Yu-Isenberg, ...</div><div class="gs_gray">Clinical therapeutics 31 (2), 421-435<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14816391248155978033" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease</a><div class="gs_gray">DA Hughes, K Bodger, P Bytzer, D de Herdt, D Dubois</div><div class="gs_gray">Pharmacoeconomics 23 (10), 1031-1041<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12336662540992887299" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation</a><div class="gs_gray">CL Mallucci, MD Jenkinson, EJ Conroy, JC Hartley, M Brown, J Dalton, ...</div><div class="gs_gray">The Lancet 394 (10208), 1530-1539<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8365537129035884004" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Profitability and market value of orphan drug companies: a retrospective, propensity-matched case-control study</a><div class="gs_gray">DA Hughes, J Poletti-Hughes</div><div class="gs_gray">PLOS one 11 (10), e0164681<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8025627800111487651" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Conducting economic evaluations alongside randomised trials: current methodological issues and novel approaches</a><div class="gs_gray">D Hughes, J Charles, D Dawoud, RT Edwards, E Holmes, C Jones, ...</div><div class="gs_gray">Pharmacoeconomics 34 (5), 447-461<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11208448714377801824" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:sszUF3NjhM4C" class="gsc_a_at">Value-based pricing</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">Pharmacoeconomics 29 (9), 731-735<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17716894340955576328" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:uWiczbcajpAC" class="gsc_a_at">The problem of orphan drugs</a><div class="gs_gray">RE Ferner, DA Hughes</div><div class="gs_gray">Bmj 341<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9329144263841094900" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:GtLg2Ama23sC" class="gsc_a_at">The difference between effectiveness and efficacy of antimalarial drugs in Kenya</a><div class="gs_gray">AA Amin, DA Hughes, V Marsh, TO Abuya, GO Kokwaro, PA Winstanley, ...</div><div class="gs_gray">Tropical Medicine &amp; International Health 9 (9), 967-974<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11716497195021168313" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Predicting “real world” effectiveness by integrating adherence with pharmacodynamic modeling</a><div class="gs_gray">DA Hughes, T Walley</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 74 (1), 1-8<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4341588427837369603" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:PELIpwtuRlgC" class="gsc_a_at">Decision-makers’ preferences for approving new medicines in wales: a discrete-choice experiment with assessment of external validity</a><div class="gs_gray">WG Linley, DA Hughes</div><div class="gs_gray">Pharmacoeconomics 31 (4), 345-355<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7247682420480644369" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Public health interventions to promote mental well-being in people aged 65 and over: systematic review of effectiveness and cost-effectiveness</a><div class="gs_gray">G Windle, D Hughes, P Linck, R Morgan, V Burholt, RT Edwards, ...</div><div class="gs_gray">Bangor: Institute of Medical and Social Care Research. favourable processes&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5837771074597342410" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:CdxZDUztZiMC" class="gsc_a_at">Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence</a><div class="gs_gray">DA Hughes, D Dubois</div><div class="gs_gray">Pharmacoeconomics 22 (16), 1047-1059<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16564532096777668573" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">Pharmacogenetic tests: the need for a level playing field</a><div class="gs_gray">M Pirmohamed, DA Hughes</div><div class="gs_gray">Nature reviews Drug discovery 12 (1), 3-4<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14547252991395341081" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:hMod-77fHWUC" class="gsc_a_at">Folate Augmentation of Treatment–Evaluation for Depression (FolATED): protocol of a randomised controlled trial</a><div class="gs_gray">SH Roberts, E Bedson, D Hughes, K Lloyd, S Moat, M Pirmohamed, ...</div><div class="gs_gray">BMC psychiatry 7 (1), 1-19<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2788916637622765472" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Cost effectiveness analysis of <i>HLA-B*58:01</i> genotyping prior to initiation of allopurinol for gout</a><div class="gs_gray">CO Plumpton, A Alfirevic, M Pirmohamed, DA Hughes</div><div class="gs_gray">Rheumatology 56 (10), 1729-1739<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2507324562183758487" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:Ehil0879vHcC" class="gsc_a_at">Rationing of drugs for rare diseases</a><div class="gs_gray">D Hughes</div><div class="gs_gray">Pharmacoeconomics 24 (4), 315-316<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13411396594263398541" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">ESPACOMP medication adherence reporting guidelines (EMERGE): a reactive-Delphi study protocol</a><div class="gs_gray">R Helmy, LL Zullig, J Dunbar-Jacob, DA Hughes, B Vrijens, IB Wilson, ...</div><div class="gs_gray">BMJ open 7 (2), e013496<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2647225380878628125" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone</a><div class="gs_gray">JA Simpson, D Hughes, C Manyando, K Bojang, L Aarons, P Winstanley, ...</div><div class="gs_gray">British journal of clinical pharmacology 61 (3), 289-300<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4702340578209267632" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Core items for a standardized resource use measure: expert Delphi consensus survey</a><div class="gs_gray">JC Thorn, ST Brookes, C Ridyard, R Riley, DA Hughes, S Wordsworth, ...</div><div class="gs_gray">Value in Health 21 (6), 640-649<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13086351349278093820" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:8xutWZnSdmoC" class="gsc_a_at">Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden</a><div class="gs_gray">TI Verhoef, WK Redekop, S Langenskiold, F Kamali, M Wadelius, ...</div><div class="gs_gray">The pharmacogenomics journal 16 (5), 478-484<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13512481821024955014" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Reimbursement decisions of the all wales medicines strategy group</a><div class="gs_gray">WG Linley, DA Hughes</div><div class="gs_gray">Pharmacoeconomics 30 (9), 779-794<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1002623428690501415" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:UuEBAcK4md4C" class="gsc_a_at">The effect of masterbatch addition on the mechanical, thermal, optical and surface properties of poly (lactic acid)</a><div class="gs_gray">F Byrne, PG Ward, J Kennedy, N Imaz, D Hughes, DP Dowling</div><div class="gs_gray">Journal of Polymers and the Environment 17 (1), 28-33<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11525757326006501256" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled&nbsp;…</a><div class="gs_gray">JC Blair, A McKay, C Ridyard, K Thornborough, E Bedson, M Peak, M Didi, ...</div><div class="gs_gray">bmj 365<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5853731313702380828" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:IWHjjKOFINEC" class="gsc_a_at">A risk–benefit assessment of prasugrel, clopidogrel, and genotype‐guided therapy in patients undergoing percutaneous coronary intervention</a><div class="gs_gray">GF Guzauskas, DA Hughes, SM Bradley, DL Veenstra</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 91 (5), 829-837<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2125909195370721761" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:hkOj_22Ku90C" class="gsc_a_at">A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives</a><div class="gs_gray">TI Verhoef, WK Redekop, J Darba, M Geitona, DA Hughes, U Siebert, ...</div><div class="gs_gray">Pharmacogenomics 11 (7), 989-1002<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7860838944592677461" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation</a><div class="gs_gray">J Pink, M Pirmohamed, DA Hughes</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 94 (2), 269-276<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5544883152733125148" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:O0nohqN1r9EC" class="gsc_a_at">Trends and influences on use of antidiabetic drugs in England, 1992–2003</a><div class="gs_gray">T Walley, D Hughes, H Kendall</div><div class="gs_gray">Pharmacoepidemiology and drug safety 14 (11), 769-773<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18145800457968876968" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:Hck25ST_3aIC" class="gsc_a_at">Giant lymph node hyperplasia a diagnostic dilemma in the neck</a><div class="gs_gray">V Raut, J Cullen, D Hughes</div><div class="gs_gray">Auris Nasus Larynx 28 (2), 185-188<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15632060394972008482" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:BqipwSGYUEgC" class="gsc_a_at">Innovation at the intersection of clinical trials and real‐world data science to advance patient care</a><div class="gs_gray">B Swift, L Jain, C White, V Chandrasekaran, A Bhandari, DA Hughes, ...</div><div class="gs_gray">Clinical and translational science 11 (5), 450-460<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3142127384193576966" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Taxonomy for methods of resource use measurement</a><div class="gs_gray">CH Ridyard, DA Hughes, DIRUM Team</div><div class="gs_gray">Health economics 24 (3), 372-378<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15595050811086123982" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Opportunity costs and local health service spending decisions: a qualitative study from Wales</a><div class="gs_gray">SK Schaffer, J Sussex, D Hughes, N Devlin</div><div class="gs_gray">BMC health services research 16 (1), 1-13<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8912094166062086225" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:u9iWguZQMMsC" class="gsc_a_at">Generalisability and cost-impact of antibiotic-impregnated central venous catheters for reducing risk of bloodstream infection in paediatric intensive care units in England</a><div class="gs_gray">K Harron, Q Mok, D Hughes, B Muller-Pebody, R Parslow, P Ramnarayan, ...</div><div class="gs_gray">PloS one 11 (3), e0151348<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5275720241146258733" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:rmuvC79q63oC" class="gsc_a_at">Beyond registration—measuring the public-health potential of new treatments for malaria in Africa</a><div class="gs_gray">T Lang, D Hughes, T Kanyok, J Kengeya-Kayondo, V Marsh, A Haaland, ...</div><div class="gs_gray">The Lancet Infectious Diseases 6 (1), 46-52<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11388646706709055108" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:mUJArPsKIAAC" class="gsc_a_at">The development of a consistent Europe-wide approach to investigating the economic impact of myalgic encephalomyelitis (ME/CFS): A report from the European Network on ME/CFS&nbsp;…</a><div class="gs_gray">DFH Pheby, D Araja, U Berkis, E Brenna, J Cullinan, JD de Korwin, L Gitto, ...</div><div class="gs_gray">Healthcare 8 (2), 88<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11078141573548582821" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Affordable orphan drugs: a role for not‐for‐profit organizations</a><div class="gs_gray">EH Davies, E Fulton, D Brook, DA Hughes</div><div class="gs_gray">British journal of clinical pharmacology 83 (7), 1595-1601<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12944725382215672071" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Warfarin Pharmacogenetics</a><div class="gs_gray">DA Hughes, M Pirmohamed</div><div class="gs_gray">Pharmacoeconomics 25 (11), 899-902<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10462842805597163839" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children</a><div class="gs_gray">K Harron, Q Mok, K Dwan, CH Ridyard, T Moitt, M Millar, P Ramnarayan, ...</div><div class="gs_gray">Health technology assessment 20 (18)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12099128742166974639" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Adherence and variability in warfarin dose requirements: assessment in a prospective cohort</a><div class="gs_gray">AL Jorgensen, DA Hughes, A Hanson, D Van Eker, CH Toh, ...</div><div class="gs_gray">Pharmacogenomics 14 (2), 151-163<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7438221906879693382" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs</a><div class="gs_gray">TI Verhoef, WK Redekop, RMF Van Schie, S Bayat, AK Daly, M Geitona, ...</div><div class="gs_gray">Pharmacogenomics 13 (12), 1405-1417<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16327993357301096395" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Review of therapeutically equivalent alternatives to short acting β2 adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers</a><div class="gs_gray">DA Hughes, A Woodcock, T Walley</div><div class="gs_gray">Thorax 54 (12), 1087-1092<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10268019400634250026" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:43bX7VzcjpAC" class="gsc_a_at">Societal perspective on access to publicly subsidised medicines: a cross sectional survey of 3080 adults in Australia</a><div class="gs_gray">L Chim, G Salkeld, P Kelly, W Lipworth, DA Hughes, MR Stockler</div><div class="gs_gray">PloS one 12 (3), e0172971<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15367910053848268396" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:PyEswDtIyv0C" class="gsc_a_at">Mechanism-based approach to the economic evaluation of pharmaceuticals</a><div class="gs_gray">J Pink, S Lane, DA Hughes</div><div class="gs_gray">Pharmacoeconomics 30 (5), 413-429<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17662393778453531760" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Biosimilars: evidential standards for health technology assessment</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 87 (3), 257-261<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12541850128917400594" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:rTD5ala9j4wC" class="gsc_a_at">Patient compliance with drug therapy for diabetic nephropathy</a><div class="gs_gray">D Hughes, B Manns</div><div class="gs_gray">Cmaj 162 (11), 1553-1553<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13263703555781205044" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:GFxP56DSvIMC" class="gsc_a_at">Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery</a><div class="gs_gray">G Powell, EAF Holmes, CO Plumpton, A Ring, GA Baker, A Jacoby, ...</div><div class="gs_gray">British journal of clinical pharmacology 80 (5), 1149-1159<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13516142737385942710" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:sSrBHYA8nusC" class="gsc_a_at">‘Seizure First Aid Training’for people with epilepsy who attend emergency departments, and their family and friends: study protocol for intervention development and a pilot&nbsp;…</a><div class="gs_gray">AJ Noble, AG Marson, C Tudur-Smith, M Morgan, DA Hughes, ...</div><div class="gs_gray">BMJ open 5 (7), e009040<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5856622878730414249,6274398284799501797" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=_q2u5IIAAAAJ:olpn-zPbct0C" class="gsc_a_at">Societal preferences for funding orphan drugs in the United Kingdom: an application of person trade-off and discrete choice experiment methods</a><div class="gs_gray">SM Bourke, CO Plumpton, DA Hughes</div><div class="gs_gray">Value in Health 21 (5), 538-546<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6757909885579460745" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Economic impact of emergency visits due to drug-related morbidity on a Brazilian hospital</a><div class="gs_gray">GRM de Freitas, MY Tramontina, G Balbinotto, DA Hughes, I Heineck</div><div class="gs_gray">Value in health regional issues 14, 1-8<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4212517221317921340" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Comparing generic and condition-specific preference-based measures in epilepsy: EQ-5D-3L and NEWQOL-6D</a><div class="gs_gray">B Mulhern, J Pink, D Rowen, S Borghs, T Butt, D Hughes, A Marson, ...</div><div class="gs_gray">Value in Health 20 (4), 687-693<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17135749130474339852" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Adherence of patients to long-term medication: a cross-sectional study of antihypertensive regimens in Austria</a><div class="gs_gray">F Lötsch, L Auer-Hackenberg, M Groger, K Rehman, V Morrison, ...</div><div class="gs_gray">Wiener klinische Wochenschrift 127 (9), 379-384<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8399832888551549538" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:abG-DnoFyZgC" class="gsc_a_at">Estimating drug costs in economic evaluations in Ireland and the UK</a><div class="gs_gray">DA Hughes, L Tilson, M Drummond</div><div class="gs_gray">Pharmacoeconomics 27 (8), 635-643<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4627290612702698266" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:wE-fMHVdjMkC" class="gsc_a_at">The Thyrotropin‐Releasing Hormone Secretory System in the Hypothalamus of the Siberian Hamster in Long and Short Photoperiods</a><div class="gs_gray">FJP Ebling, D Wilson, J Wood, D Hughes, JG Mercer, PJ Morgan, ...</div><div class="gs_gray">Journal of neuroendocrinology 20 (5), 576-586<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13318679400707813788" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population</a><div class="gs_gray">B Mulhern, D Rowen, D Snape, A Jacoby, T Marson, D Hughes, G Baker, ...</div><div class="gs_gray">Epilepsy &amp; Behavior 36, 12-17<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9770941141823567325" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">From NCE to NICE: the role of pharmacoeconomics</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">British journal of clinical pharmacology 70 (3), 317<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14151029263723812568" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Abolition of prescription copayments in Wales: an observational study on dispensing rates</a><div class="gs_gray">D Cohen, MF Alam, FDJ Dunstan, S Myles, DA Hughes, PA Routledge</div><div class="gs_gray">Value in Health 13 (5), 675-680<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15470214814339585438" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Cost and clinical consequence of antibiotic non-adherence in acute exacerbations of chronic bronchitis</a><div class="gs_gray">SV Sorensen, T Baker, R Fleurence, J Dixon, C Roberts, S Haider, ...</div><div class="gs_gray">The International journal of tuberculosis and lung disease 13 (8), 945-954<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6147001150376894625" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:foquWX3nUaYC" class="gsc_a_at">Less is more: medicines that require less frequent administration improve adherence, but are they better?</a><div class="gs_gray">D Hughes</div><div class="gs_gray">Pharmacoeconomics 24 (3), 211-213<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10650625296981532342" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Using routinely recorded data in the UK to assess outcomes in a randomised controlled trial: The Trials of Access</a><div class="gs_gray">GA Powell, LJ Bonnett, C Tudur-Smith, DA Hughes, PR Williamson, ...</div><div class="gs_gray">Trials 18 (1), 1-11<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14137041353642257418" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">Climate influences on the cost-effectiveness of vector-based interventions against malaria in elimination scenarios</a><div class="gs_gray">PE Parham, DA Hughes</div><div class="gs_gray">Philosophical Transactions of the Royal Society B: Biological Sciences 370&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18026574370966737930" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Economic impact of poor compliance with pharmaceuticals</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">Expert review of pharmacoeconomics &amp; outcomes research 2 (4), 327-335<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2425428669309227266" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non&nbsp;…</a><div class="gs_gray">A Marson, G Burnside, R Appleton, D Smith, JP Leach, G Sills, ...</div><div class="gs_gray">The Lancet 397 (10282), 1375-1386<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=449511925882629484" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT</a><div class="gs_gray">J Blair, A McKay, C Ridyard, K Thornborough, E Bedson, M Peak, M Didi, ...</div><div class="gs_gray">Health Technology Assessment 22<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2358474140539004368" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimens</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">British journal of clinical pharmacology 65 (6), 871-878<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2633579905332761343" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:1taIhTC69MYC" class="gsc_a_at">Cost‐Effectiveness of Panel Tests for Multiple Pharmacogenes Associated With Adverse Drug Reactions: An Evaluation Framework</a><div class="gs_gray">CO Plumpton, M Pirmohamed, DA Hughes</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 105 (6), 1429-1438<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15644159564886586492" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:anf4URPfarAC" class="gsc_a_at">Impact of non‐adherence on the safety and efficacy of uric acid‐lowering therapies in the treatment of gout</a><div class="gs_gray">D Hill‐McManus, E Soto, S Marshall, S Lane, D Hughes</div><div class="gs_gray">British journal of clinical pharmacology 84 (1), 142-152<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11900196929178552113" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">A systematic review of patients’ perspectives on the subcutaneous route of medication administration</a><div class="gs_gray">CH Ridyard, DMM Dawoud, LV Tuersley, DA Hughes</div><div class="gs_gray">The Patient-Patient-Centered Outcomes Research 9 (4), 281-292<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2769976216087287015" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Pregnancy related pituitary enlargement mimicking macroadenoma</a><div class="gs_gray">AH Heald, D Hughes, A King, H Buckler</div><div class="gs_gray">British journal of neurosurgery 18 (5), 524-526<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15407502503536749368" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Impact of non-adherence and flare resolution on the cost-effectiveness of treatments for gout: application of a linked pharmacometric/pharmacoeconomic model</a><div class="gs_gray">D Hill-McManus, S Marshall, E Soto, S Lane, D Hughes</div><div class="gs_gray">Value in Health 21 (12), 1373-1381<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4663563932757057747" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Economics of Pharmacogenetic‐Guided Treatments: Underwhelming or Overstated?</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 103 (5), 749-751<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10305209232908459439" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Abolition of prescription charges in Wales: the impact on medicines use in those who used to pay</a><div class="gs_gray">S Groves, D Cohen, MF Alam, FDJ Dunstan, PA Routledge, DA Hughes, ...</div><div class="gs_gray">International Journal of Pharmacy Practice 18 (6), 332-340<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4168182279428609801" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Cost-effectiveness analysis of the use of point-of-care C-reactive protein testing to reduce antibiotic prescribing in primary care</a><div class="gs_gray">EAF Holmes, SD Harris, A Hughes, N Craine, DA Hughes</div><div class="gs_gray">Antibiotics 7 (4), 106<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5590559041415965287" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HGTzPopzzJcC" class="gsc_a_at">What influences persistence with medicines? A multinational discrete choice experiment of 2549 patients</a><div class="gs_gray">EAF Holmes, VL Morrison, DA Hughes</div><div class="gs_gray">British journal of clinical pharmacology 82 (2), 522-531<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17344946618156670464" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:lSLTfruPkqcC" class="gsc_a_at">A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile&nbsp;…</a><div class="gs_gray">A Ramanan, A Dick, A McKay, A Jones, P Williamson, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology 67, 3931-3933<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3473861246798246837,17297619384890305103" class="gsc_a_ac gs_ibl">11</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="_q2u5IIAAAAJ:lSLTfruPkqcC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence</a><div class="gs_gray">CO Plumpton, I Brown, M Reuber, AG Marson, DA Hughes</div><div class="gs_gray">Epilepsy &amp; Behavior 45, 180-186<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7782532143859048378" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:9pM33mqn1YgC" class="gsc_a_at">A systematic review and empirical analysis of the relation between dose and duration of drug action</a><div class="gs_gray">DA Hughes, JK Aronson</div><div class="gs_gray">The Journal of Clinical Pharmacology 50 (1), 17-26<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14812060990762515014" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-nhnvRiOwuoC" class="gsc_a_at">A systematic review of economic evaluations of advanced therapy medicinal products</a><div class="gs_gray">H Lloyd‐Williams, DA Hughes</div><div class="gs_gray">British journal of clinical pharmacology 87 (6), 2428-2443<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2768848616533340154" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Core Health Outcomes in Childhood Epilepsy (CHOICE): development of a core outcome set using systematic review methods and a Delphi survey consensus</a><div class="gs_gray">H Crudgington, M Rogers, L Bray, B Carter, J Currier, C Dunkley, ...</div><div class="gs_gray">Epilepsia 60 (5), 857-871<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3798420007249452402" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-7ulzOJl1JYC" class="gsc_a_at">Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis</a><div class="gs_gray">DA Hughes, G Culeddu, CO Plumpton, E Wood, AD Dick, AP Jones, ...</div><div class="gs_gray">Ophthalmology 126 (3), 415-424<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17216496962475074481" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:e_rmSamDkqQC" class="gsc_a_at">Study protocol for a randomised controlled trial of insulin delivery by continuous subcutaneous infusion compared to multiple daily injections</a><div class="gs_gray">J Blair, JW Gregory, D Hughes, CH Ridyard, C Gamble, A McKay, M Didi, ...</div><div class="gs_gray">Trials 16 (1), 1-9<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10446177939345723114" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Pharmacoeconomics</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">British journal of clinical pharmacology 73 (6), 968<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2070614025311460204" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Pharmacoeconomics: principles and relevance to the activities of drug and therapeutics committees</a><div class="gs_gray">D Hughes, DJM Reynolds</div><div class="gs_gray">Clinical medicine 9 (5), 490<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10822374207723180490" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Feasibility, validity and reliability of the Welsh version of the EQ-5D health status questionnaire</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">Quality of Life Research 16 (8), 1419-1423<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11661636108773806205,3285385336608538686" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">A Literature Review of GP Knowledge and Understanding of ME/CFS: A Report from the Socioeconomic Working Group of the European Network on ME/CFS (EUROMENE)</a><div class="gs_gray">DFH Pheby, D Araja, U Berkis, E Brenna, J Cullinan, JD de Korwin, L Gitto, ...</div><div class="gs_gray">Medicina 57 (1), 7<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6180049496613345818" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:BrOSOlqYqPUC" class="gsc_a_at">Acute chloroquine poisoning: a comprehensive experimental toxicology assessment of the role of diazepam</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">British journal of pharmacology 177 (21), 4975-4989<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5244853974563352843" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Patient‐Focused Drug Development Methods for Benefit–Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs</a><div class="gs_gray">EAF Holmes, C Plumpton, GA Baker, A Jacoby, A Ring, P Williamson, ...</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 105 (3), 672-683<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13549004148793819769" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Core Health Outcomes In Childhood Epilepsy (CHOICE): protocol for the selection of a core outcome set</a><div class="gs_gray">C Morris, C Dunkley, FM Gibbon, J Currier, D Roberts, M Rogers, ...</div><div class="gs_gray">Trials 18 (1), 1-8<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=611523654081909696" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Xz60mAmATU4C" class="gsc_a_at">Magnetic non-equivalence in the methylene group of an ethyl ester</a><div class="gs_gray">GE Hall, D Hughes, D Rae, AP Rhodes</div><div class="gs_gray">Tetrahedron Letters 8 (3), 241-246<span class="gs_oph">, 1967</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12700590338389269559" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1967</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:T_ojBgVMvoEC" class="gsc_a_at">The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority&nbsp;…</a><div class="gs_gray">A Marson, G Burnside, R Appleton, D Smith, JP Leach, G Sills, ...</div><div class="gs_gray">The Lancet 397 (10282), 1363-1374<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3698446924412705222" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.</a><div class="gs_gray">AV Ramanan, AD Dick, AP Jones, DA Hughes, A McKay, A Rosala-Hallas, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 23 (15), 1<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15516481992389426520" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Ade32sEp0pkC" class="gsc_a_at">Evaluation of a consultant audit and feedback programme to improve the quality of antimicrobial prescribing in acute medical admissions</a><div class="gs_gray">E Roberts, DM Dawoud, DA Hughes, C Cefai</div><div class="gs_gray">International Journal of Pharmacy Practice 23 (5), 333-339<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16711302340246905637" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:nPT8s1NX_-sC" class="gsc_a_at">Non-thermal plasma based technologies for the after-treatment of automotive exhaust particulates and marine diesel exhaust NOx</a><div class="gs_gray">R McAdams, P Beech, R Gillespie, C Guy, S Jones, T Liddell, R Morgan, ...</div><div class="gs_gray">Accentus plc (US); Warship Support Agency J Oesterle; GmbH&amp; Co. KG (US)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16123482473987176540" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">The new and non-transparent Cancer drugs fund</a><div class="gs_gray">EM Wood, DA Hughes</div><div class="gs_gray">PharmacoEconomics 38 (1), 1-4<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=756550108442234311" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">The SANAD II study of effectiveness of valproate or levetiracetam in generalised and unclassifiable epilepsy: an un-blinded randomised controlled trial</a><div class="gs_gray">A Marson, G Burnside, R Appleton, JP Leach, G Sills, C Tudur-Smith, ...</div><div class="gs_gray">Epilepsia 60, 25-25<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16677059920165367164" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">New medicines in Wales: the all Wales medicines strategy group (AWMSG) appraisal process and outcomes</a><div class="gs_gray">A Varnava, R Bracchi, K Samuels, DA Hughes, PA Routledge</div><div class="gs_gray">PharmacoEconomics 36 (5), 613-624<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13065237042200249378" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">Cost-effectiveness of pediatric central venous catheters in the UK: a secondary publication from the CATCH clinical trial</a><div class="gs_gray">CH Ridyard, CO Plumpton, RE Gilbert, DA Hughes</div><div class="gs_gray">Frontiers in pharmacology 8, 644<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14107752667749389707" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:zGdJYJv2LkUC" class="gsc_a_at">Comparative study of the processing conditions required for PLA and PET polymers</a><div class="gs_gray">F Byrne, PG Ward, D Hughes, J Cullen, DP Dowling</div><div class="gs_gray">Proceedings of the IMF Conference. Waterford Institute of Technology<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2047757635276343338" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:RJOyoaXV5v8C" class="gsc_a_at">Perceptions of European ME/CFS Experts Concerning Knowledge and Understanding of ME/CFS among Primary Care Physicians in Europe: A Report from the European ME/CFS Research&nbsp;…</a><div class="gs_gray">J Cullinan, DFH Pheby, D Araja, U Berkis, E Brenna, JD de Korwin, L Gitto, ...</div><div class="gs_gray">Medicina 57 (3), 208<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4343464303778026082" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:k_7cPK9k7w8C" class="gsc_a_at">Early impact of COVID-19 social distancing measures on reported sexual behaviour of HIV pre-exposure prophylaxis users in Wales</a><div class="gs_gray">D Gillespie, C Knapper, D Hughes, Z Couzens, F Wood, M De Bruin, ...</div><div class="gs_gray">Sexually transmitted infections 97 (2), 85-87<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15261212135776082571" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:w0F2JDEymm0C" class="gsc_a_at">CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in homebased dying patients (CARiAD): study protocol for a UK-based open randomised pilot trial</a><div class="gs_gray">M Poolman, J Roberts, A Byrne, P Perkins, Z Hoare, A Nelson, J Hiscock, ...</div><div class="gs_gray">Trials 20 (1), 1-16<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18438778232618311253" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Health utilities and costs for motor neurone disease</a><div class="gs_gray">A Moore, CA Young, DA Hughes</div><div class="gs_gray">Value in Health 22 (11), 1257-1265<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7152609322387856461" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Improving Medication adherence research reporting: European Society for Patient Adherence, Compliance and Persistence medication adherence reporting guideline</a><div class="gs_gray">S De Geest, LL Zullig, J Dunbar-Jacob, D Hughes, IB Wilson, B Vrijens</div><div class="gs_gray">Journal of Cardiovascular Nursing 34 (3), 199-200<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12224886054725622064" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:TQgYirikUcIC" class="gsc_a_at">Ring-fencing a budget for cancer drugs: is it fair?</a><div class="gs_gray">J Graham, J Cassidy, D Hughes, M Duerden</div><div class="gs_gray">The journal of the Royal College of Physicians of Edinburgh 41 (3), 224-228<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2440499942996890553" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">Modelling the effects of stratigraphical uncertainty on fault seal and trap-fill in faulted structures</a><div class="gs_gray">SM Clarke, M Littler, SD Burley, GD Williams, D Hughes, S Coogan</div><div class="gs_gray">Petroleum Geoscience 12 (2), 143-156<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16926779969600142690" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ye4kPcJQO24C" class="gsc_a_at">Ches</a><div class="gs_gray">EM Hughes</div><div class="gs_gray">History 13, 13-18<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4923721149066841929" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Challenges for economic evaluation of health care strategies to contain antimicrobial resistance</a><div class="gs_gray">EAF Holmes, DA Hughes</div><div class="gs_gray">Antibiotics 8 (4), 166<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6447740494973378018" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:SpbeaW3--B0C" class="gsc_a_at">What really matters? A mixed methods study of treatment preferences and priorities among people with epilepsy in the UK</a><div class="gs_gray">A Ring, A Jacoby, G Baker, E Holmes, D Hughes, C Kierans, A Marson</div><div class="gs_gray">Epilepsy &amp; Behavior 95, 181-191<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10528117412610403643" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Nerve root block versus surgery (NERVES) for the treatment of radicular pain secondary to a prolapsed intervertebral disc herniation: study protocol for a multi-centre&nbsp;…</a><div class="gs_gray">MJ Wilby, C Hopkins, E Bedson, S Howlin, G Burnside, EJ Conroy, ...</div><div class="gs_gray">Trials 19 (1), 1-7<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12591275926431252795" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Mapping ALSFRS-R and ALSUI to EQ-5D in patients with motor neuron disease</a><div class="gs_gray">A Moore, CA Young, DA Hughes</div><div class="gs_gray">Value in Health 21 (11), 1322-1329<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15243428116795063541" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:rO6llkc54NcC" class="gsc_a_at">Community views on factors affecting medicines resource allocation: cross-sectional survey of 3080 adults in Australia</a><div class="gs_gray">L Chim, G Salkeld, PJ Kelly, W Lipworth, DA Hughes, MR Stockler</div><div class="gs_gray">Australian Health Review 43 (3), 254-260<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17183143203287551582" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Economic studies in motor neurone disease: a systematic methodological review</a><div class="gs_gray">A Moore, CA Young, DA Hughes</div><div class="gs_gray">Pharmacoeconomics 35 (4), 397-413<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=363096909323541680" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Review of resource-use measures in UK economic evaluations</a><div class="gs_gray">CH Ridyard, D Hughes</div><div class="gs_gray">Unit Costs of Health and Social Care 2015, 22-31<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3374716834762299048" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:hC7cP41nSMkC" class="gsc_a_at">An agenda for UK clinical pharmacology: pharmacoeconomics</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">British Journal of Clinical Pharmacology 73 (6), 968-972<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2263374503867315024" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">HTAs and rare diseases: How to assess their cost-effectiveness</a><div class="gs_gray">CJ Phillips, DA Hughes</div><div class="gs_gray">Pharmaceuticals Policy and Law 13 (3, 4), 161-165<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8510189119778862218" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:UxriW0iASnsC" class="gsc_a_at">NHS and charitable funding for children and young people with cancer in England and Wales</a><div class="gs_gray">P Linck, B Tunnage, DA Hughes, RT Edwards</div><div class="gs_gray">Journal of Child Health Care 12 (2), 156-168<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5041117590997169353" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:3bvyWxjaHKcC" class="gsc_a_at">Medication adherence—Key considerations for clinical pharmacologists</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">British journal of clinical pharmacology 86 (4), 628<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14319849654974261056" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Rare disease prevention and treatment: The need for a level playing field</a><div class="gs_gray">DA Hughes, CO Plumpton</div><div class="gs_gray">Pharmacogenomics 19 (3), 243-247<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18237136698675896015" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:yB1At4FlUx8C" class="gsc_a_at">A randomised, patient-assessor blinded, sham-controlled trial of external non-invasive peripheral nerve stimulation for chronic neuropathic pain following peripheral nerve&nbsp;…</a><div class="gs_gray">S Johnson, R Richey, E Holmes, D Hughes, A Goebel</div><div class="gs_gray">Trials 17 (1), 1-10<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8907638004034130861" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Identification of items for a standardised resource-use measure: review of current instruments</a><div class="gs_gray">J Thorn, C Ridyard, R Riley, S Brookes, D Hughes, S Wordsworth, ...</div><div class="gs_gray">Trials 16 (2), 1-1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7562583403136671333" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">New advice on switching antiepileptic drugs might be a false economy</a><div class="gs_gray">E Holmes, C Plumpton, M Duerden, T Marson, D Hughes</div><div class="gs_gray">Bmj 347<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11173731756323166459" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:eflP2zaiRacC" class="gsc_a_at">Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease</a><div class="gs_gray">DA Hughes, M Marchetti, G Colombo</div><div class="gs_gray">Expert review of pharmacoeconomics &amp; outcomes research 5 (1), 29-38<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6263360483537322696" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">report on the determinants of patient non-adherence with short-term therapies and treatments for chronic diseases in Europe</a><div class="gs_gray">P Kardas, V Morrison, E Fargher, S Parveen, C Plumpton, W Clyne, ...</div><div class="gs_gray">Ascertaining barriers for compliance: policies for safe, effective and cost&nbsp;…<span class="gs_oph">, 3</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3421283033935667928" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">3</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:SGW5VrABaM0C" class="gsc_a_at">Managing access to advanced therapy medicinal products: Challenges for NHS Wales</a><div class="gs_gray">AR Champion, S Lewis, S Davies, DA Hughes</div><div class="gs_gray">British Journal of Clinical Pharmacology 87 (6), 2444-2449<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13222487486629112860" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LXmCCkuhhTsC" class="gsc_a_at">What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics</a><div class="gs_gray">A Albassam, DA Hughes</div><div class="gs_gray">European journal of clinical pharmacology 77 (2), 251-260<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5202857802600347265" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Value assessment and quantitative benefit-risk modelling of biosimilar infliximab for Crohn’s Disease</a><div class="gs_gray">H Catt, K Bodger, JJ Kirkham, DA Hughes</div><div class="gs_gray">PharmacoEconomics 37 (12), 1509-1523<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1193513567007722776" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:tYavs44e6CUC" class="gsc_a_at">Developing patient-centred, feasible alternative care for adult emergency department users with epilepsy: protocol for the mixed-methods observational ‘Collaborate’project</a><div class="gs_gray">AJ Noble, A Mathieson, L Ridsdale, EA Holmes, M Morgan, A McKinlay, ...</div><div class="gs_gray">BMJ open 9 (11), e031696<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9839062186416263789" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:cWzG1nlazyYC" class="gsc_a_at">Systematic review: outcomes and adverse events from randomised trials in Crohn's disease</a><div class="gs_gray">H Catt, D Hughes, JJ Kirkham, K Bodger</div><div class="gs_gray">Alimentary pharmacology &amp; therapeutics 49 (8), 978-996<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12826156751502601486" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:KaMxkj08jr0C" class="gsc_a_at">Do guidelines for treating chest disease in children use Cochrane Reviews effectively? A systematic review</a><div class="gs_gray">AP Prayle, T Cox, SJ Smith, J Rycroft-Malone, KS Thomas, DA Hughes, ...</div><div class="gs_gray">Thorax 73 (7), 670-673<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17198992422241107570" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Impact of the phased abolition of co‐payments on the utilisation of selected prescription medicines in Wales</a><div class="gs_gray">MF Alam, D Cohen, F Dunstan, D Hughes, P Routledge</div><div class="gs_gray">Health economics 27 (1), 236-243<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1403974998880903157" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">Renal transplant patients’ preference for the supply and delivery of immunosuppressants in Wales: a discrete choice experiment</a><div class="gs_gray">A Hagemi, C Plumpton, DA Hughes</div><div class="gs_gray">BMC nephrology 18 (1), 1-8<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12833302415908327417" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:BzfGm06jWhQC" class="gsc_a_at">Cost-effectiveness of HLA-B* 15: 02 screening in Malaysia</a><div class="gs_gray">C Plumpton, D Hughes</div><div class="gs_gray">British Journal of Dermatology 177 (4), 904-905<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15381391306018070884" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC): a randomised controlled trial of adalimumab injection compared with placebo for patients receiving&nbsp;…</a><div class="gs_gray">NH Williams, A Jenkins, N Goulden, Z Hoare, DA Hughes, E Wood, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 21 (60), 1-180<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7862573369133362285" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kw52XkFRtyQC" class="gsc_a_at">Health economics analysis plans: where are we now?</a><div class="gs_gray">JC Thorn, CH Ridyard, D Hughes, S Wordsworth, B Mihaylova, S Noble, ...</div><div class="gs_gray">Value in Health 19 (7), A397<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15686817399537244992" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:4DMP91E08xMC" class="gsc_a_at">THU0213 adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis: the sycamore trial</a><div class="gs_gray">AV Ramanan, AD Dick, AP Jones, A McKay, PR Williamson, ...</div><div class="gs_gray">Annals of the Rheumatic Diseases 75 (Suppl 2), 264-265<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1666088753157763657" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:QUX0mv85b1cC" class="gsc_a_at">Opportunity costs and local health service spending decisions: a qualitative study from Wales.</a><div class="gs_gray">J Sussex, D Hughes, N Devlin</div><div class="gs_gray">BMC Health Services Research 16, 103-103<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13472583889995577931" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:DUooU5lO8OsC" class="gsc_a_at">The Cost Of Drug-Related Morbidity That Lead To Emergency Visits In A Brazilian Hospital</a><div class="gs_gray">G Freitas, G Balbinotto, D Hughes, I Heineck</div><div class="gs_gray">Value in Health 18 (3), A16-A17<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12206123294029876380" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:oPLKW5k6eA4C" class="gsc_a_at">Synthesis of major findings at PUB 2011 and recommendations for future directions</a><div class="gs_gray">DA Hughes, C Spence, R Woods</div><div class="gs_gray">Putting Prediction in Ungauged Basins into Practice: Papers derived from a&nbsp;…<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11709899464597114392" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:CYCckWUYoCcC" class="gsc_a_at">ISPOR Personalized Medicine Special Interest Group. Challenges in the development and reimbursement of personalized medicine: payer and manufacturer perspectives and&nbsp;…</a><div class="gs_gray">E Faulkner, GL AL, M Helfand, A Holtorf, J Hornberger, D Hughes, T Li, ...</div><div class="gs_gray">Value in Health 15, 1162-1171<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12276094530018239548" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Br1UauaknNIC" class="gsc_a_at">Ascertaining barriers to compliance: Policies for safe, effective and cost-effective use of medicines in Europe</a><div class="gs_gray">A Andrzejczyk, W Clyne, S De Geest, J Demonceau, F Dobbels, ...</div><div class="gs_gray">Ascertaining Barriers for Compliance<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16382834387457924274" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Ring-fencing a budget for cancer drugs: is it fair?</a><div class="gs_gray">DA Hughes, J Graham</div><div class="gs_gray">JR Coll Physicians Edinb 41, 224-8<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9077966897315887730" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:geHnlv5EZngC" class="gsc_a_at">Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report</a><div class="gs_gray">B Mulhern, D Rowen, J Brazier, A Jacoby, T Marson, D Snape, D Hughes, ...</div><div class="gs_gray">Sheffield<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5974490808619517013" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:69ZgNCALVd0C" class="gsc_a_at">SYSTEMATIC REVIEWS-Follow-up of cancer in primary care versus secondary care: Systematic review</a><div class="gs_gray">RA Lewis, RD Neal, NH Williams, B France, M Hendry, D Russell, ...</div><div class="gs_gray">British Journal of General Practice 59 (564), 525<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17023871686642939568" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:VLnqNzywnoUC" class="gsc_a_at">A prototype agent-based model of antimalarial drug compliance</a><div class="gs_gray">J McKean, S Rahlf, H Shorter, G Barnish, R Paton, P McBurney, ...</div><div class="gs_gray">Second International Workshop on Agent-based Models of Market Dynamics and&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8590841025454253727" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Orphan drugs revisited: author's response</a><div class="gs_gray">D Hughes</div><div class="gs_gray">Journal of the Association of Physicians 99 (5), 350-351<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8279384697059774065" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:IsPWOBWtZBwC" class="gsc_a_at">Linked Pharmacometric‐Pharmacoeconomic Modeling and Simulation in Clinical Drug Development</a><div class="gs_gray">D Hill‐McManus, S Marshall, J Liu, RJ Willke, DA Hughes</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 110 (1), 49-63<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10501187382113180006" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kF1pexMAQbMC" class="gsc_a_at">TEOS: A framework for constructing operational definitions of medication adherence based on Timelines–Events–Objectives–Sources</a><div class="gs_gray">AL Dima, SS Allemann, J Dunbar‐Jacob, DA Hughes, B Vrijens, IB Wilson</div><div class="gs_gray">British Journal of Clinical Pharmacology 87 (6), 2521-2533<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16585464893997437616" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ziOE8S1-AIUC" class="gsc_a_at">Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT.</a><div class="gs_gray">CL Mallucci, MD Jenkinson, EJ Conroy, JC Hartley, M Brown, T Moitt, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 24 (17), 1<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12964522115924214277" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:EPG8bYD4jVwC" class="gsc_a_at">Impact of relaxing Covid-19 social distancing measures on rural North Wales: a simulation analysis</a><div class="gs_gray">RP Hughes, DA Hughes</div><div class="gs_gray">Frontiers in Public Health 8, 933<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10622878276339400956" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:IRz6iEL74y4C" class="gsc_a_at">Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D Feasibility): a randomised&nbsp;…</a><div class="gs_gray">A Farmer, J Allen, K Bartlett, P Bower, Y Chi, D French, B Gudgin, ...</div><div class="gs_gray">BMJ open 9 (12), e033504<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12387421588127271913" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Medicines Shortages in the United Kingdom</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">Clinical pharmacology and therapeutics 106 (4), 712<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10876797405222761077" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials</a><div class="gs_gray">D Johnson, D Hughes, M Pirmohamed, A Jorgensen</div><div class="gs_gray">Journal of personalized medicine 9 (3), 42<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7312202514675355863" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">Integration of pharmacometrics and pharmacoeconomics to quantify the value of improved forgiveness to nonadherence: a case study of novel xanthine oxidase inhibitors for gout</a><div class="gs_gray">D Hill‐McManus, S Marshall, E Soto, DA Hughes</div><div class="gs_gray">Clinical Pharmacology &amp; Therapeutics 106 (3), 652-660<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7186126752152616978" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">A fully integrated real-time detection, diagnosis, and control of community diarrheal disease clusters and outbreaks (the INTEGRATE Project): protocol for an enhanced&nbsp;…</a><div class="gs_gray">KM McIntyre, FJ Bolton, RM Christley, P Cleary, E Deja, AE Durie, ...</div><div class="gs_gray">JMIR research protocols 8 (9), e13941<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15110127241020161761" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica&nbsp;…</a><div class="gs_gray">NH Williams, A Jenkins, N Goulden, Z Hoare, DA Hughes, E Wood, ...</div><div class="gs_gray">Trials 19 (1), 1-12<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14488070988753084071" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:hGdtkIFZdKAC" class="gsc_a_at">Carer-administration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients: a UK study (CARIAD)</a><div class="gs_gray">C Wilkinson, M Poolman, J Roberts, B Wee, J Hiscock, D Hughes, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14549820452255996462" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">How pharmaceutical companies profit from drugs for rare diseases</a><div class="gs_gray">DA Hughes, J Poletti-Hughes</div><div class="gs_gray">The Conversation<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6998186608082092555" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">NICE recommendations: why no disinvestment recommendations to offset investment decisions?</a><div class="gs_gray">DA Hughes, EM Wood, L Tuersley</div><div class="gs_gray">Bmj 350<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2061106408949345998" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Opportunity Costs of Implementing Nice Decisions in NHS Wales</a><div class="gs_gray">SS Karlsberg, J Sussex, D Hughes, N Devlin</div><div class="gs_gray">Value in Health 17 (7), A422<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3246678591915247471" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:2l5NCbZemmgC" class="gsc_a_at">Methods</a><div class="gs_gray">E Bedson, D Bell, D Carr, B Carter, D Hughes, A Jorgensen, H Lewis, ...</div><div class="gs_gray">Folate Augmentation of Treatment–Evaluation for Depression (FolATED&nbsp;…<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=765866766451276941" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:35N4QoGY0k4C" class="gsc_a_at">Opportunity Costs of Implementing NICE Decisions in NHS Wales</a><div class="gs_gray">S Karlsberg Schaffer, J Sussex, D Hughes, N Devlin</div><div class="gs_gray">Office of Health Economics Research Papers<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3621826520699222992" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">Review of the use of resource use instruments based on patient recall in relation to other methods of resource use estimation</a><div class="gs_gray">C Ridyard, D Hughes</div><div class="gs_gray">Trials 14 (1), 1-1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6478510132680011157" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LGlY6t8CeOMC" class="gsc_a_at">PHP163 Pharmaceutical Innovation: Definition, and Mechanisms for Reward</a><div class="gs_gray">D Hughes</div><div class="gs_gray">Value in Health 14 (7), A363<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8256893928744437053" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">PMS39 MOST EFFECTIVE ADHERENCE-ENHANCING INTERVENTIONS FOR OSTEOPOROSIS MEDICATIONS</a><div class="gs_gray">M Hiligsmann, M Salas, DA Hughes, E Manias, F Gwadry-Sridhar, P Linck, ...</div><div class="gs_gray">Value in Health 14 (3), A130<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1973731389267156273" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">PGI2 BIOLOGICAL AGENTS FOR THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A SYSTEMATIC REVIEW, META-ANALYSIS AND MULTIPLE TREATMENT COMPARISON</a><div class="gs_gray">D Hughes, T Kikuchi, K Bodger</div><div class="gs_gray">Value in Health 3 (10), A147<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15237873161651295343" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:TlpoogIpr_IC" class="gsc_a_at">Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Pharmacy Practice Research Trust biennial awards seminar, London, UK<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1772349698705385446" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Health economic aspects of patient non-compliance</a><div class="gs_gray">D Hughes</div><div class="gs_gray">Patient compliance: sweetening the pill, 23-40<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8581508761291256840" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Analysis of the Potential Economic Impact of Guidance of Improving Outcomes for People with Brain and other CNS Tumours</a><div class="gs_gray">PG Linck, P Linck, E Priedane, DA Hughes, RT Edwards</div><div class="gs_gray">Unknown<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5255247210284809622" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Analysis of the Potential Economic Impact of Guidance of improving Outcomes for Children and Young People with Cancer</a><div class="gs_gray">P Linck, B Tunnage, DA Hughes, RT Edwards</div><div class="gs_gray">Unknown<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6379272339420493396" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:k_IJM867U9cC" class="gsc_a_at">The influence of non-compliance on the effectiveness and cost-effectiveness of drug therapies.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14951685370401295462" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:MIg0yeAD4ggC" class="gsc_a_at">The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE)</a><div class="gs_gray">DFH Pheby, D Araja, U Berkis, E Brenna, J Cullinan, JD de Korwin, L Gitto, ...</div><div class="gs_gray">Medicina 57 (4), 388<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18151071175854104522" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:tHtfpZlB6tUC" class="gsc_a_at">Mycophenolate mofetil versus cyclophosphamide for remission induction in childhood polyarteritis nodosa: An open label, randomised, Bayesian, non‐inferiority trial</a><div class="gs_gray">PA Brogan, B Arch, H Hickey, J Anton, E Iglesias, E Baildam, K Mahmood, ...</div><div class="gs_gray">Arthritis &amp; Rheumatology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17769400185084497097" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:qe6vwMD2xtsC" class="gsc_a_at">Acceptability of generic versus innovator oral medicines: not only a matter of taste</a><div class="gs_gray">C Tuleu, DA Hughes, D Clapham, T Vallet, F Ruiz</div><div class="gs_gray">Drug Discovery Today<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7027335872440553223" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Xl6nMSl579sC" class="gsc_a_at">Seizure first aid training for people with epilepsy attending emergency departments and their significant others: the SAFE intervention and feasibility RCT</a><div class="gs_gray">A Noble, S Nevitt, E Holmes, L Ridsdale, M Morgan, C Tudur-Smith, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1338513232159931507" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Management of patients symptomatically unresponsive to levothyroxine: natural desiccated thyroid extract or the combination of levothyroxine and liothyronine? A research priority</a><div class="gs_gray">A Heald, M Livingston, D Hughes</div><div class="gs_gray">Experimental and Clinical Endocrinology &amp; Diabetes 128 (09), 596-598<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11166982105232210328" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for&nbsp;…</a><div class="gs_gray">S Balabanova, C Taylor, G Sills, G Burnside, C Plumpton, PEM Smith, ...</div><div class="gs_gray">BMJ open 10 (8), e040635<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5676454913533922351" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:An6A6Jpfc1oC" class="gsc_a_at">Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.</a><div class="gs_gray">M Poolman, J Roberts, S Wright, A Hendry, N Goulden, EAF Holmes, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 24 (25), 1<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6048683776376261437" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A&nbsp;…</a><div class="gs_gray">A Alshreef, N Latimer, P Tappenden, R Wong, D Hughes, J Fotheringham, ...</div><div class="gs_gray">Medical Decision Making 39 (8), 910-925<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11899934298972319363" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Clinical trial simulation and value of information to optimise design of clinical trials from a pharmaceutical industry perspective</a><div class="gs_gray">D Hill-McManus, D Hughes</div><div class="gs_gray">TRIALS 20<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10313642493419925151" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma</a><div class="gs_gray">MD Jenkinson, DC Weber, BJ Haylock, FC Sherratt, B Young, M Weller, ...</div><div class="gs_gray">Journal of neurosurgery 129 (4), 1104-1105<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9259898282696932264" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Health economics analysis plans: the current state of play</a><div class="gs_gray">J Thorn, C Ridyard, D Hughes, S Wordsworth, B Mihaylova, S Noble, ...</div><div class="gs_gray">4th International Clinical Trials Methodology Conference (ICTMC) and the&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6634090020292751522" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:5MTHONV0fEkC" class="gsc_a_at">P12. 10 The ROAM/EORTC 1308 trial: Radiation versus observation following surgical resection of atypical meningioma-study update</a><div class="gs_gray">MD Jenkinson, M Javadpour, BJ Haylock, B Young, H Bulbeck, M Farrell, ...</div><div class="gs_gray">Neuro-oncology 19 (suppl_3), iii97-iii97<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13642227495748357800" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Pragmatic randomised, controlled trial of impregnated central venous catheters for preventing bloodstream infection in children</a><div class="gs_gray">R Gilbert, Q Mok, K Dwan, K Harron, T Moitt, M Millar, P Ramnarayan, ...</div><div class="gs_gray">Lancet<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6683300133059077789" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Review of the Use of Resource Use Instruments Based on Patient Recall in Relation to Other Methods of Cost Estimation</a><div class="gs_gray">C Ridyard, P Linck, DA Hughes</div><div class="gs_gray">Value in Health 16 (7), A466<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18284052911738896158" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Dem6FJhTUoYC" class="gsc_a_at">Patient preferences and priorities for anti-epileptic drug treatment</a><div class="gs_gray">EA Fargher, A Marson, A Jacoby, A Ring, P Williamson, DA Hughes</div><div class="gs_gray">Value in Health 16 (7), A626<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17321469931696482212" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:738O_yMBCRsC" class="gsc_a_at">Cost Effectiveness of Pharmacogenetic Screening Prior to Initiation of Carbamazepine Treatment for Epilepsy</a><div class="gs_gray">CO Plumpton, V Yip, A Alfirevic, A Marson, M Pirmohamed, DA Hughes</div><div class="gs_gray">Value in Health 16 (7), A624<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5539974957761662055" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:SdhP9T11ey4C" class="gsc_a_at">2 Consensus on European Taxonomy and Terminology of Patient Compliance</a><div class="gs_gray">B Vrijens, S De Geest, D Hughes, P Kardas, J Demonceau, T Ruppar, ...</div><div class="gs_gray">Ascertaining Barriers for Compliance: policies for safe, effective and cost&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7501411160640773090" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:p2g8aNsByqUC" class="gsc_a_at">7 Report on the cost effectiveness of interventions that promote adherence: a systematic review of the literature and economic evaluation</a><div class="gs_gray">E Fargher, D Hughes</div><div class="gs_gray">Ascertaining Barriers for Compliance: policies for safe, effective and cost&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5258910173139931190" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:SP6oXDckpogC" class="gsc_a_at">Interventions to improve patients compliance with lipid lowering medications: A systematic review of the literature</a><div class="gs_gray">A Zuluaga, M Salas, FH Gwadry-Sridhar, E Manias, DA Hughes</div><div class="gs_gray">Pharmacoepidemiology and Drug Safety, S356-S356<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5112611200425044964" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:JQOojiI6XY0C" class="gsc_a_at">Erratum to: Folate Augmentation of Treatment–Evaluation for Depression (FolATED): protocol of a randomised controlled trial</a><div class="gs_gray">SH Roberts, E Bedson, DA Hughes, KR Lloyd, DB Menkes, SJ Moat, ...</div><div class="gs_gray">BMC Psychiatry 9 (1), 1-2<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8018105880676306118" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Medicines concordance and game theory</a><div class="gs_gray">D Hughes</div><div class="gs_gray">British journal of clinical pharmacology 66 (4), 577<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15443313784299874430" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HJSXoJQnj-YC" class="gsc_a_at">PHP4 FACTORS INFLUENCING USER CHOICES TO VISIT EITHER GENERAL PRACTITIONERS OR COMMUNITY PHARMACISTS FOR MINOR AILMENTS—A DISCRETE CHOICE EXPERIMENT</a><div class="gs_gray">D Hughes, S Myles, M Longo, C Lisles, K Hood</div><div class="gs_gray">Value in Health 3 (10), A23<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9560034838390420047" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Improving Outcomes for People with Sarcoma-Analysis of Potential Economic Impact.</a><div class="gs_gray">PG Linck, P Linck, DA Hughes, RT Edwards</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9152711034839180262" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:z_wVstp3MssC" class="gsc_a_at">Improving Outcomes for People with Brain and Other CNS Tumours: Analysis of the Potential Economic Impact of the Guidance.</a><div class="gs_gray">P Linck, E Priedane, DA Hughes, RT Edwards</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8714435027566315489" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">PCV5: IMPACT OF NON-COMPLIANCE ON THE COSTEFFECTIVENESS OF STATIN THERAPY</a><div class="gs_gray">DA Hughes, A Bagust</div><div class="gs_gray">Value in Health 4 (6), 489-490<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3328895544974850174" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:raTqNPD5sRQC" class="gsc_a_at">Utilising benefit-risk assessments within clinical trials—a protocol for the BRAINS project</a><div class="gs_gray">N Totton, S Julious, D Hughes, J Cook, K Biggs, L Coates, A Cook, ...</div><div class="gs_gray">Trials 22 (1), 1-5<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:wSy_KLzO7YEC" class="gsc_a_at">Mechanistically Informed Non-invasive Peripheral Nerve Stimulation for Peripheral Neuropathic Pain: a Randomised Double-blind Sham-controlled Trial.</a><div class="gs_gray">A Marshall, D Hughes, E Holmes, F Henrich, T Nurmikko, M Sharma, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:X0DADzN9RKwC" class="gsc_a_at">Pharmacogenomics spotlight commentary: From the United Kingdom to global populations</a><div class="gs_gray">EF Magavern, AK Daly, A Gilchrist, D Hughes</div><div class="gs_gray">British Journal of Clinical Pharmacology, 14917<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:z8nqeaKD1nsC" class="gsc_a_at">Cost-effectiveness of home versus hospital management of children at onset of type 1 diabetes: the DECIDE randomised controlled trial</a><div class="gs_gray">Z McCarroll, J Townson, T Pickles, JW Gregory, R Playle, M Robling, ...</div><div class="gs_gray">BMJ open 11 (5), e043523<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Wq2b2clWBLsC" class="gsc_a_at">Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open&nbsp;…</a><div class="gs_gray">MJ Wilby, A Best, E Wood, G Burnside, E Bedson, H Short, D Wheatley, ...</div><div class="gs_gray">The Lancet Rheumatology 3 (5), e347-e356<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:QsaTk4IG4EwC" class="gsc_a_at">A Randomised Controlled Trial of Surgical Microdiscectomy Versus Trans-Foraminal Epidural Steroid Injection for Sciatica of Up to 1 Year; The NERVES Trial</a><div class="gs_gray">MJ Wilby, A Best, E Wood, G Burnside, E Bedson, H Short, D Wheatley, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:NxmKEeNBbOMC" class="gsc_a_at">Using Routinely Recorded Data in a UK RCT: A Comparison to Standard Prospective Data Collection Methods</a><div class="gs_gray">G Powell, L Bonnett, C Tudor-Smith, D Hughes, PR Williamson, ...</div><div class="gs_gray">Trials<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:A8cqit5AE6sC" class="gsc_a_at">Economic evaluation</a><div class="gs_gray">MJ Wilby, A Best, E Wood, G Burnside, E Bedson, H Short, D Wheatley, ...</div><div class="gs_gray">Microdiscectomy compared with transforaminal epidural steroid injection for&nbsp;…<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:z6xuaG2dYH0C" class="gsc_a_at">Clinical effectiveness results</a><div class="gs_gray">MJ Wilby, A Best, E Wood, G Burnside, E Bedson, H Short, D Wheatley, ...</div><div class="gs_gray">Microdiscectomy compared with transforaminal epidural steroid injection for&nbsp;…<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-6RzNnnwWf8C" class="gsc_a_at">Microdiscectomy compared with transforaminal epidural steroid injection for persistent radicular pain caused by prolapsed intervertebral disc: the NERVES RCT.</a><div class="gs_gray">MJ Wilby, A Best, E Wood, G Burnside, E Bedson, H Short, D Wheatley, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 25 (24), 1<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Content of Health Economics Analysis Plans (HEAPs) for trial-based economic evaluations: expert Delphi consensus survey</a><div class="gs_gray">JC Thorn, CF Davies, ST Brookes, SM Noble, M Dritsaki, E Gray, ...</div><div class="gs_gray">Value in Health 24 (4), 539-547<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:D_tqNUsBuKoC" class="gsc_a_at">Pharmacogenomics; From the UK to global populations</a><div class="gs_gray">E Magavern, A Daly, A Gilchrist, D Hughes</div><div class="gs_gray">Authorea Preprints<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:eAlLMO4JVmQC" class="gsc_a_at">Support through mobile messaging and digital health technology for diabetes (SuMMiT-D): feasibility of economic evaluation</a><div class="gs_gray">EAF Holmes, A Farmer, DA Hughes</div><div class="gs_gray">International Journal of Clinical Pharmacy 43 (1)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:AYInfyleIOsC" class="gsc_a_at">Patient and public engagement in medication adherence research</a><div class="gs_gray">EAF Holmes, D Gillespie, DA Hughes</div><div class="gs_gray">INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 43 (1), 305-305<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:0aBXIfxlw9sC" class="gsc_a_at">EstablishINg the best STEp-up treatments for children with uncontrolled asthma despite INhaled corticosteroids (EINSTEIN): protocol for a systematic review, network meta&nbsp;…</a><div class="gs_gray">S Cividini, I Sinha, S Donegan, M Maden, G Culeddu, K Rose, O Fulton, ...</div><div class="gs_gray">BMJ open 11 (2), e040528<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:OzeSX8-yOCQC" class="gsc_a_at">Cost-Effectiveness Analysis of Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa</a><div class="gs_gray">G Culeddu, PA Brogan, D Hughes</div><div class="gs_gray">Health Technology Assessment International 2021<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:L_l9e5I586QC" class="gsc_a_at">Protocol: EstablishINg the best STEp-up treatments for children with uncontrolled asthma despite INhaled corticosteroids (EINSTEIN): protocol for a systematic review, network&nbsp;…</a><div class="gs_gray">S Cividini, I Sinha, S Donegan, M Maden, G Culeddu, K Rose, O Fulton, ...</div><div class="gs_gray">BMJ Open 11 (2)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Combining Model‐Based Clinical Trial Simulation, Pharmacoeconomics, and Value of Information to Optimize Trial Design</a><div class="gs_gray">D Hill‐McManus, DA Hughes</div><div class="gs_gray">CPT: pharmacometrics &amp; systems pharmacology 10 (1), 75-83<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of&nbsp;…</a><div class="gs_gray">RA Lewis, D Hughes, AJ Sutton, C Wilkinson</div><div class="gs_gray">PharmacoEconomics 39 (1), 25-61<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">RTID-10. SURGEONS TRIAL OF PROPHYLAXIS FOR EPILEPSY IN SEIZURE NAÏVE PATIENTS WITH MENINGIOMA: A RANDOMIZED CONTROLLED TRIAL (STOP ‘EM)</a><div class="gs_gray">M Jenkinson, A Helmy, H Huckey, S Mills, R Grant, D Hughes, T Marson, ...</div><div class="gs_gray">Neuro-Oncology 22 (Supplement_2), ii195-ii195<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:JWITY9-sCbMC" class="gsc_a_at">Pharmacists must embrace pharmacogenetic services before other professions beat them to it</a><div class="gs_gray">D Hughes</div><div class="gs_gray">Evaluation 14, 34<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Sign the All Trials petition</a><div class="gs_gray">A Bithell, P Baker, A Blenkinsopp, M Borthwick, AR Cox, R Davies, ...</div><div class="gs_gray">Evaluation 14, 34<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:qE4H1tSSYIIC" class="gsc_a_at">Outcomes of the pilot randomised controlled trial and implications for a definitive trial</a><div class="gs_gray">A Noble, S Nevitt, E Holmes, L Ridsdale, M Morgan, C Tudur-Smith, ...</div><div class="gs_gray">Seizure first aid training for people with epilepsy attending emergency&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:UmS_249rOGwC" class="gsc_a_at">Part B: pilot RCT–methods</a><div class="gs_gray">A Noble, S Nevitt, E Holmes, L Ridsdale, M Morgan, C Tudur-Smith, ...</div><div class="gs_gray">Seizure first aid training for people with epilepsy attending emergency&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:SIv7DqKytYAC" class="gsc_a_at">Part A: intervention development</a><div class="gs_gray">A Noble, S Nevitt, E Holmes, L Ridsdale, M Morgan, C Tudur-Smith, ...</div><div class="gs_gray">Seizure first aid training for people with epilepsy attending emergency&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:sA9dB-pw3HoC" class="gsc_a_at">Economic evaluation</a><div class="gs_gray">A Noble, S Nevitt, E Holmes, L Ridsdale, M Morgan, C Tudur-Smith, ...</div><div class="gs_gray">Seizure first aid training for people with epilepsy attending emergency&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">Intervention fidelity</a><div class="gs_gray">A Noble, S Nevitt, E Holmes, L Ridsdale, M Morgan, C Tudur-Smith, ...</div><div class="gs_gray">Seizure first aid training for people with epilepsy attending emergency&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:2ywjKiB__4kC" class="gsc_a_at">HTA OF ADVANCED THERAPY MEDICINAL PRODUCTS</a><div class="gs_gray">H Lloyd-Williams, D Hughes</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:pS0ncopqnHgC" class="gsc_a_at">Embedded qualitative study: carers</a><div class="gs_gray">M Poolman, J Roberts, S Wright, A Hendry, N Goulden, EAF Holmes, ...</div><div class="gs_gray">Carer administration of as-needed subcutaneous medication for breakthrough&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">Randomised pilot trial design and methods</a><div class="gs_gray">M Poolman, J Roberts, S Wright, A Hendry, N Goulden, EAF Holmes, ...</div><div class="gs_gray">Carer administration of as-needed subcutaneous medication for breakthrough&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:DkZNVXde3BIC" class="gsc_a_at">Developing the intervention</a><div class="gs_gray">M Poolman, J Roberts, S Wright, A Hendry, N Goulden, EAF Holmes, ...</div><div class="gs_gray">Carer administration of as-needed subcutaneous medication for breakthrough&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:qwy9JoKyICEC" class="gsc_a_at">Seizure First Aid Training For people with Epilepsy (SAFE) and significant others attending emergency departments: intervention development and pilot RCT</a><div class="gs_gray">A Noble, S Nevitt, E Holmes, L Ridsdale, M Morgan, C Tudur Smith, ...</div><div class="gs_gray">Health Services and Delivery Research<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Seizure First Aid Training For people with Epilepsy (SAFE) frequently attending emergency departments and their significant others: results of a UK multi-centre randomised&nbsp;…</a><div class="gs_gray">AJ Noble, D Snape, S Nevitt, EA Holmes, M Morgan, C Tudur-Smith, ...</div><div class="gs_gray">BMJ open 10 (4), e035516<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Economic evaluation</a><div class="gs_gray">CL Mallucci, MD Jenkinson, EJ Conroy, JC Hartley, M Brown, T Moitt, ...</div><div class="gs_gray">Silver-impregnated, antibiotic-impregnated or non-impregnated&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kzcSZmkxUKAC" class="gsc_a_at">Clinical effectiveness study: additional data</a><div class="gs_gray">CL Mallucci, MD Jenkinson, EJ Conroy, JC Hartley, M Brown, T Moitt, ...</div><div class="gs_gray">Silver-impregnated, antibiotic-impregnated or non-impregnated&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:jSAVyFp_754C" class="gsc_a_at">Protocol: Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard&nbsp;…</a><div class="gs_gray">S Balabanova, C Taylor, G Sills, G Burnside, C Plumpton, PEM Smith, ...</div><div class="gs_gray">BMJ Open 10 (8)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Health utility of people with treatment-resistant hypothyroidism as measured with the EQ-5D-5L quality of life questionnaire</a><div class="gs_gray">D Hughes, J Townson, E Owen-Jones, R Playle, I Khan, R Kochhar, ...</div><div class="gs_gray">Society for Endocrinology BES 2019 65<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:7H_MAutzIkAC" class="gsc_a_at">A novel approach to benefit-risk assessment of surgical resection of colorectal liver metastases</a><div class="gs_gray">E Holmes, L Jones, S Gollins, D Hughes, S Fenwick</div><div class="gs_gray">BRITISH JOURNAL OF SURGERY 106, 6-7<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kWvqk_afx_IC" class="gsc_a_at">MRC-NIHR methodology guideline development on utilising benefit-risk assessments within clinical trials</a><div class="gs_gray">N Totton, S Julious, D Hughes, J Cook</div><div class="gs_gray">Trials 20 (Supplement 1), 93-93<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:jgBuDB5drN8C" class="gsc_a_at">The impact of alternative assumptions on QALY calculations in the presence of missing data</a><div class="gs_gray">CO Plumpton, DA Hughes</div><div class="gs_gray">TRIALS 20<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Essential items for a Health Economics Analysis Plan (HEAP): expert Delphi consensus survey</a><div class="gs_gray">J Thorn, CF Davies, ST Brookes, M Dritsaki, E Gray, D Hughes, SM Noble, ...</div><div class="gs_gray">TRIALS 20<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:RGFaLdJalmkC" class="gsc_a_at">A discrete choice experiment to measure public preferences for genetic testing to prevent adverse drug reactions</a><div class="gs_gray">D Johnson, A Jorgensen, D Hughes, SM Pirmohamed</div><div class="gs_gray">TRIALS 20<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:N5tVd3kTz84C" class="gsc_a_at">Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout (vol 84, pg 142, 2018)</a><div class="gs_gray">D Hill-McManus, E Soto, S Marshall, S Lane, D Hughes</div><div class="gs_gray">BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 85 (8), 1865-1865<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Drug evaluation and pharmacoeconomics</a><div class="gs_gray">J Krska, DA Hughes</div><div class="gs_gray">Pharmacy Practice E-Book, 72<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">Economic evaluation</a><div class="gs_gray">AV Ramanan, AD Dick, AP Jones, DA Hughes, A McKay, A Rosala-Hallas, ...</div><div class="gs_gray">Adalimumab in combination with methotrexate for refractory uveitis&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Interim analysis results</a><div class="gs_gray">AV Ramanan, AD Dick, AP Jones, DA Hughes, A McKay, A Rosala-Hallas, ...</div><div class="gs_gray">Adalimumab in combination with methotrexate for refractory uveitis&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:4vMrXwiscB8C" class="gsc_a_at">Trial design and methods</a><div class="gs_gray">AV Ramanan, AD Dick, AP Jones, DA Hughes, A McKay, A Rosala-Hallas, ...</div><div class="gs_gray">Adalimumab in combination with methotrexate for refractory uveitis&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-yGd096yOn8C" class="gsc_a_at">Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply.</a><div class="gs_gray">D Hughes, G Culeddu, C Plumpton, E Wood, AD Dick, MW Beresford, ...</div><div class="gs_gray">Ophthalmology 126 (3), e24-e25<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis REPLY</a><div class="gs_gray">DA Hughes, G Culeddu, C Plumpton, E Wood, AD Dick, MW Beresford, ...</div><div class="gs_gray">OPHTHALMOLOGY 126 (3), E24-E25<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ijdKiLOsEJMC" class="gsc_a_at">Statistical methods for adjusting estimates of treatment effectiveness for patient nonadherence in the context of time-to-event outcomes and health technology assessment: A&nbsp;…</a><div class="gs_gray">A Alshreef, N Latimer, P Tappenden, R Wong, D Hughes, J Fotheringham, ...</div><div class="gs_gray">'SAGE Publications'<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:dAp6zn-oMfAC" class="gsc_a_at">Abualbishr Alshreef, Nicholas Latimer, Paul Tappenden</a><div class="gs_gray">R Wong, D Hughes, J Fotheringham, S Dixon</div><div class="gs_gray">Medical Decision Making 39 (8), 910-925<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Economic evaluation</a><div class="gs_gray">J Blair, A McKay, C Ridyard, K Thornborough, E Bedson, M Peak, M Didi, ...</div><div class="gs_gray">Continuous subcutaneous insulin infusion versus multiple daily injections in&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Trial design and methods</a><div class="gs_gray">J Blair, A McKay, C Ridyard, K Thornborough, E Bedson, M Peak, M Didi, ...</div><div class="gs_gray">Continuous subcutaneous insulin infusion versus multiple daily injections in&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:jmjb1lOE9QIC" class="gsc_a_at">Improving medication adherence research reporting: ESPACOMP Medication Adherence Reporting Guideline (EMERGE)</a><div class="gs_gray">S De Geest, LL Zullig, J Dunbar-Jacob, D Hughes, IB Wilson, B Vrijens</div><div class="gs_gray">Annals of internal medicine 169 (1), 30<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">PWE-007 A systematic review of outcomes and adverse events for randomised controlled trials in crohn’s disease</a><div class="gs_gray">MH Catt, D Hughes, K Bodger, J Kirkham</div><div class="gs_gray">Gut 67 (Suppl 1), A71-A71<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Seizure First Aid Training for People with Epilepsy who Attend Emergency Departments and Their Family and Friends: Results from a Pilot Randomised Controlled Trial</a><div class="gs_gray">D Snape, S Nevitt, C Tudur-Smith, S Goodacre, DA Hughes, M Morgan, ...</div><div class="gs_gray">Epilepsia 59, S140-S140<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Access to High-Cost Medicines in Wales</a><div class="gs_gray">A Varnava, S Rind, R Bracchi, K Samuels, PA Routledge, DA Hughes</div><div class="gs_gray">Equitable Access to High-Cost Pharmaceuticals, 199-213<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:MAUkC_7iAq8C" class="gsc_a_at">1151 Patients’ preferences for anti-epileptic drugs (aeds)</a><div class="gs_gray">E Holmes, G Baker, A Jacoby, A Ring, A Marson, D Hughes</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 88 (Suppl 1), A3-A4<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">PO240 Using routinely recorded data in a clinical trial</a><div class="gs_gray">G Powell, L Bonnett, C Tudur-Smith, D Hughes, P Williamson, T Marson</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 88 (Suppl 1), A75-A75<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Pump-Downloaded Insulin Usage For The First 12 Months In A Cohort of Children Newly-Diagnosed With Type 1 Diabetes (T1D)</a><div class="gs_gray">C Ridyard, J Blair, D Hughes</div><div class="gs_gray">Value in Health 20 (9), A481-A482<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-95Q15plzcUC" class="gsc_a_at">Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients: A Cost-Utility Analysis</a><div class="gs_gray">C Ridyard, J Blair, D Hughes</div><div class="gs_gray">Value in Health 20 (9), A582<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:u_35RYKgDlwC" class="gsc_a_at">Use Of The Ims Core Diabetes Model (CDM) In A Long-Term Projected Health Economic Comparison Of CSII And MDI Treatments Of Type 1 Diabetes (T1D) In A Newly-Diagnosed Population&nbsp;…</a><div class="gs_gray">C Ridyard, J Blair, D Hughes</div><div class="gs_gray">Value in Health 20 (9), A580<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:8d8msizDQcsC" class="gsc_a_at">Decision Analytic Modelling Methods For The Assessing The Effectiveness Of Treatment Sequences For Clinical And Economic Decision Making: A Methodological Review</a><div class="gs_gray">RA Lewis, DA Hughes, C Wilkinson</div><div class="gs_gray">Value in Health 20 (9), A748<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Results from the Resource Use Questionnaire for all eight randomised participants</a><div class="gs_gray">NH Williams, A Jenkins, N Goulden, Z Hoare, DA Hughes, E Wood, ...</div><div class="gs_gray">Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:5ugPr518TE4C" class="gsc_a_at">Cost-Effectiveness Of Molecular Versus Conventional Screening For Acute Intestinal Infectious Diseases: Novel Application Of Agent-Based Modelling</a><div class="gs_gray">R Bhatt, DA Hughes</div><div class="gs_gray">Value in Health 20 (9), A757<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Cost-Effectiveness Of A Multi-Gene Panel In The Context Of Reducing Adverse Drug Reactions</a><div class="gs_gray">CO Plumpton, M Pirmohamed, DA Hughes</div><div class="gs_gray">Value in Health 20 (9), A753<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Patterns In Working Days Lost By Parents Of Children Newly-Diagnosed With Type 1 Diabetes (T1D)</a><div class="gs_gray">CH Ridyard, J Blair, DA Hughes, SCIPI Trial Investigators</div><div class="gs_gray">Value in Health 20 (9), A590<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Influence Of Disease Familiarity On Implied Time Preferences For Seizure Frequency Reduction</a><div class="gs_gray">EA Holmes, V Morrison, DA Hughes</div><div class="gs_gray">Value in Health 20 (9), A689<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Societal Preferences For Funding Orphan Drugs In The UK: A Person Trade Off Study</a><div class="gs_gray">SM Bourke, CO Plumpton, DA Hughes</div><div class="gs_gray">Value in Health 20 (9), A559-A560<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">35 Carer-administration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients: a uk study (CARIAD)</a><div class="gs_gray">C Wilkinson, M Poolman, J Roberts, B Wee, J Hiscock, D Hughes, ...</div><div class="gs_gray">BMJ Supportive &amp; Palliative Care 7 (3), A360-A360<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Continuous subcutaneous insulin infusion compated to multiple daily injection regimens in children and yung people at diagnosis of type 1 diabetes: A pragmatic randomised&nbsp;…</a><div class="gs_gray">J Blair, A Mckay, C Ridyard, K Thornborough, E Bedson, M Peak, M Didi, ...</div><div class="gs_gray">10th International Meeting of Pediatric Endocrinology<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Quantitative benefit-risk modelling of infliximab biosimilar inflectra versus reference product remicade in the treatment of Crohn's disease</a><div class="gs_gray">H Catt, D Hughes, K Bodger, J Kirkham</div><div class="gs_gray">TRIALS 18<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Using routinely recorded data in a clinical trial: the feasibility, agreement and additional benefits compared to standard prospective data collection methods</a><div class="gs_gray">G Powell, L Bonnett, C Tudur-Smith, D Hughes, T Marson, P Williamson</div><div class="gs_gray">TRIALS 18<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Patient preferences for outcomes in clinical trials: implications for medicines optimization</a><div class="gs_gray">E Holmes, AG Marson, DA Hughes</div><div class="gs_gray">Trials 18<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Rituximab for the treatment of neuromyelitis optica: an application of individual patient data meta-analysis in a rare disease</a><div class="gs_gray">S Bourke, C Plumpton, CT Smith, A Jacob, D Hughes</div><div class="gs_gray">TRIALS 18<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Identifying the optimal clinical pharmacological properties of potential future medicines using clinical trial simulation</a><div class="gs_gray">D Hill-McManus, S Marshall, S Lane, E Soto, D Hughes</div><div class="gs_gray">TRIALS 18<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:EYYDruWGBe4C" class="gsc_a_at">Patient-level information and costing systems (PLICS) as a source of routinely collected cost data for trial-based economic evaluations</a><div class="gs_gray">C Ridyard, D Hughes</div><div class="gs_gray">4th International Clinical Trials Methodology Conference (ICTMC) and the&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:X9ykpCP0fEIC" class="gsc_a_at">Arterial hypertension treatment changes in Yaroslavl region: results obtained after 4 years of complex program of regional healthcare system’s improvement implementation</a><div class="gs_gray">ME Mozheyko, AV Vigdorchik, SY Eregin, NV Danilenko, IM Klimovskaya, ...</div><div class="gs_gray">Systemic Hypertension 14 (1), 23-29<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">How pharmaceutical companies profit from drugs for rare diseases</a><div class="gs_gray">J Poletti-Hughes, D Hughes</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:FiDNX6EVdGUC" class="gsc_a_at">Prof. John Urquhart</a><div class="gs_gray">A Breckenridge, D Hughes</div><div class="gs_gray">British journal of clinical pharmacology 82 (2), 573<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Drug utilization research and pharmacoeconomics</a><div class="gs_gray">C Usher, K Bennett, LG Mantovani, D Hughes</div><div class="gs_gray">Drug Utilization Research, 425<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Cost-effectiveness analysis</a><div class="gs_gray">K Harron, Q Mok, K Dwan, CH Ridyard, T Moitt, M Millar, P Ramnarayan, ...</div><div class="gs_gray">CATheter Infections in CHildren (CATCH): a randomised controlled trial and&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Clinical effectiveness: methods</a><div class="gs_gray">K Harron, Q Mok, K Dwan, CH Ridyard, T Moitt, M Millar, P Ramnarayan, ...</div><div class="gs_gray">CATheter Infections in CHildren (CATCH): a randomised controlled trial and&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">Prescribing Points</a><div class="gs_gray">C Khouri, T Jouve, S Blaise, P Carpentier, JL Cracowski, M Roustit, ...</div><div class="gs_gray">Br J Clin Pharmacol 82, 332-333<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">The trials and tribulations of accessing data from routine sources</a><div class="gs_gray">G Powell, T Marson, D Hughes, P Williamson, C Tudur-Smith</div><div class="gs_gray">Trials 16 (2), 1-1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Health-Economic Evaluation of Clostridium Difficile Infection (Cdi) And Epidemiology In England And Merseyside</a><div class="gs_gray">CA Nakamura, P Roberts, M Beadsworth, S O’Brien, M Pirmohamed, ...</div><div class="gs_gray">Value in Health 18 (7), A582<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:27LrP4qxOz0C" class="gsc_a_at">PP. 29.31: MANAGING BLOOD PRESSURE CONTROL USING HEALTH SYSTEM IMPROVEMENT PROGRAMME IN THE YAROSLAVL REGION OF RUSSIAN FEDERATION</a><div class="gs_gray">Z Baskakova, S Eregin, M Mozheiko, N Danilenko, D Hughes, ...</div><div class="gs_gray">Journal of Hypertension 33, e398<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:a0OBvERweLwC" class="gsc_a_at">Quantitative benefit-risk modelling of biosimilars: a case study of infliximab in Crohn’s disease</a><div class="gs_gray">H Catt, K Bodger, J Kirkham, D Hughes</div><div class="gs_gray">Hepatology 9 (1), 27-34<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-DxkuPiZhfEC" class="gsc_a_at">Modernization of hypertension treatment in the Yaroslavl region: interim results of the yearly comprehensive program for modernization of the regional healthcare system</a><div class="gs_gray">ME Mozheyko, SY Eregin, AV Vigdorchik, IM Klimovskaia, F Riahi, ...</div><div class="gs_gray">Systemic Hypertension 11 (4), 30-36<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">How Useful Are Health Psychology Theories At Predicting Adherence To Medications? A Systematic Review of Empirical Studies</a><div class="gs_gray">E Fargher Holmes, DA Hughes, V Morrison</div><div class="gs_gray">Value in Health<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">ESGCT and NVGCT Collaborative Congress: The Hague-23 to 26 October Abstracts</a><div class="gs_gray">E Vroom, A Aartsma-Rus, RC Hoeben, H Büning, H Abken, M Pegtel, ...</div><div class="gs_gray">Human Gene Therapy 25 (11), A1-A121<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:tuHXwOkdijsC" class="gsc_a_at">Recruitment into clinical trials</a><div class="gs_gray">E Bedson, D Bell, D Carr, B Carter, D Hughes, A Jorgensen, H Lewis, ...</div><div class="gs_gray">Folate Augmentation of Treatment–Evaluation for Depression (FolATED&nbsp;…<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Analysis plan</a><div class="gs_gray">E Bedson, D Bell, D Carr, B Carter, D Hughes, A Jorgensen, H Lewis, ...</div><div class="gs_gray">Folate Augmentation of Treatment–Evaluation for Depression (FolATED&nbsp;…<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">Opportunity Costs of Implementing Nice Decisions in NHS Wales</a><div class="gs_gray">J Sussex, D Hughes, N Devlin</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:RuPIJ_LgqDgC" class="gsc_a_at">The European Society for Gene and Cell Therapy and the Spanish Society for Gene and Cell Therapy Collaborative Congress 2013 Conference Abstracts Palacio Municipal de Congresos&nbsp;…</a><div class="gs_gray">C Bonini, R Hernandez, J Canals, SJ Forbes, KM Champion, A Galy, ...</div><div class="gs_gray">Human Gene Therapy 24 (12), A1-A172<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:v6i8RKmR8ToC" class="gsc_a_at">Simulating the Potential Impact of Improved Blood Pressure Control on Clinical and Economic Outcomes in Russia</a><div class="gs_gray">A Kontsevaya, P Alperin, K Shum, JA Eriksson, A Vigdorchik, S Shalnova, ...</div><div class="gs_gray">Value in Health 16 (7), A539<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:uVUOdF_882EC" class="gsc_a_at">Persistence with Medications: A Discrete Choice Experiment of Preferences Among Hypertensive Patients</a><div class="gs_gray">EA Fargher, V Morrison, CO Plumpton, DA Hughes</div><div class="gs_gray">Value in Health 16 (7), A532<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">Orphan Drug Legislations: Heyday or Had Their Day?</a><div class="gs_gray">M Palmer, DA Hughes</div><div class="gs_gray">Value in Health 16 (7), A491<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:vbGhcppDl1QC" class="gsc_a_at">Application of Behavioural Economics to the Understanding of Adherence: Does an Individual’s Time Preference Influence Adherence to Medications?</a><div class="gs_gray">EA Fargher, V Morrison, CO Plumpton, DA Hughes</div><div class="gs_gray">Value in Health 16 (7), A327-A328<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">The Multimodel Ensemble Approach to Reducing Structural Uncertainty in Decision Analytical Modelling</a><div class="gs_gray">PE Parham, DA Hughes</div><div class="gs_gray">Value in Health 16 (7), A324-A325<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Screening log data can be used to inform protocol modifications, increasing patient recrutiment to a challanging clinical trial</a><div class="gs_gray">J Blair, L Awoyale, K Thornborough, M Peak, M Didi, E Bedson, D Hughes, ...</div><div class="gs_gray">Endocrine Abstracts 33<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Multiple Imputation Techniques for Survey Data with Multiple Rating Scales</a><div class="gs_gray">CO Plumpton, DA Hughes, IR White</div><div class="gs_gray">Value in Health 16 (7), A611<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">A Systematic Review of Patient Preferences for Subcutaneous Medications</a><div class="gs_gray">C Ridyard, D Dawoud, DA Hughes</div><div class="gs_gray">Value in Health 16 (7), A335-A336<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Using discrete choice experiments to define patient preferences for outcomes in trials</a><div class="gs_gray">E Fargher, D Hughes, A Ring, A Jacoby, M Rawnsley, A Marson</div><div class="gs_gray">Trials 14 (1), 1-1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:hvmnpdAuIbkC" class="gsc_a_at">Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation</a><div class="gs_gray">D Hughes, J Pink, M Pirmohamed, S Lane, DA Hughes</div><div class="gs_gray">Clinical Pharmacology and Therapeutics<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">The economics of personalised medicine and pharmacogenetic testing</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">Clinical Therapeutics 35 (8), e118<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">P09 The Use of Cochrane Reviews in Clinical Guidelines For Respiratory Disease in Children in the United Kingdom–a Systematic Review</a><div class="gs_gray">THN Cox, AR Smyth, AP Prayle, DA Hughes, J Rycroft-Malone, K Thomas</div><div class="gs_gray">Archives of Disease in Childhood 98 (Suppl 1), A5-A5<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:CNPyR2KL9-0C" class="gsc_a_at">British Society for Gene and Cell Therapy (BSGCT) Conference Abstracts Royal Holloway University of London 17–19 April, 2013</a><div class="gs_gray">C Denning, GM Ellison, K Mitrophanous, L Seymour, JCI Belmonte, ...</div><div class="gs_gray">Human Gene Therapy 24 (5), A1-A42<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:jtI9f0ekYq0C" class="gsc_a_at">Pharmacogenetic tests: the need for a level playing field</a><div class="gs_gray">D Hughes, M Pirmohamed, DA Hughes</div><div class="gs_gray">Nature Reviews Drug Discovery 12 (3-4)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">ELICITING PATIENTS’PREFERENCES FOR EPILEPSY DIAGNOSTICS: A DISCRETE CHOICE EXPERIMENT</a><div class="gs_gray">EA Fargher, A Marson, A Jacoby, A Ring, P Williamson, DA Hughes</div><div class="gs_gray">VALUE IN HEALTH 16, A323-A636<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:zwpXiJ37cpgC" class="gsc_a_at">Reimbursement Decisions of the All Wales Medicines Strategy Group</a><div class="gs_gray">D Hughes, WG Linley, DA Hughes</div><div class="gs_gray">PharmoEconomics 30 (9), 779-794<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:mWEH9CqjF64C" class="gsc_a_at">A MULTI-NATIONAL SURVEY OF NON-ADHERENCE BY PATIENTS PRESCRIBED MEDICATION FOR HYPERTENSION</a><div class="gs_gray">V Morrison, S Parveen, E Fargher, C Plumpton, D Hughes</div><div class="gs_gray">INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE 19, S318-S319<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">APPLICATION OF BEHAVIOURAL ECONOMICS TO UNDERSTANDING ADHERENCE: STATED PREFERENCES FOR PERSISTENCE WITH MEDICATIONS</a><div class="gs_gray">EA Fargher, V Morrison, CO Plumpton, DA Hughes</div><div class="gs_gray">INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE 19, S286-S287<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">4 Application of health psychology and economic behavioural models to explain medication adherence in adult patients: a systematic review of empirical studies</a><div class="gs_gray">E Fargher, V Morrison, D Hughes</div><div class="gs_gray">Ascertaining Barriers for Compliance: policies for safe, effective and cost&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">6 Identification and assessment of adherence-enhancing interventions</a><div class="gs_gray">J Demonceau, T Ruppar, P Kristanto, DA Hughes, E Fargher, P Kardas, ...</div><div class="gs_gray">Ascertaining Barriers for Compliance: policies for safe, effective and cost&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-uzm3Y7AvW0C" class="gsc_a_at">British Society for Gene Therapy 2012 March 9, 2012 UCL Institute of Child Health, London</a><div class="gs_gray">SH Cheng, N Smart, N Cartier, I Pizzitola, F Anjos-Afonso, V Marin, ...</div><div class="gs_gray">Human Gene Therapy 23 (5), A1-A22<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Authors' reply to Zermansky and Khatib</a><div class="gs_gray">DA Hughes, J Pink, S Lane, M Pirmohamed</div><div class="gs_gray">BMJ: British Medical Journal (Online) 343<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:GnPB-g6toBAC" class="gsc_a_at">DABIGATRAN V WARFARIN Authors' reply to Zermansky and Khatib</a><div class="gs_gray">DA Hughes, J Pink, S Lane, M Pirmohamed</div><div class="gs_gray">BRITISH MEDICAL JOURNAL 343<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:RtRctb2lSbAC" class="gsc_a_at">European Society of Gene and Cell Therapy British Society for Gene Therapy Collaborative Congress 2011 October 27–31, 2011 The Brighton Centre, Brighton United Kingdom</a><div class="gs_gray">LW Seymour, M Antoniou, DRP Harbottle, C Denning, R Hajjar, S Ferber, ...</div><div class="gs_gray">Human Gene Therapy 22 (10), A1-A138<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Generic substitution: authors' response</a><div class="gs_gray">DA Hughes, MG Duerden</div><div class="gs_gray">British Journal of Clinical Pharmacology 71 (6), 968<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:WZBGuue-350C" class="gsc_a_at">PHARMACOECONOMIC ASPECTS OF RATIONAL MEDICINES USE: S6</a><div class="gs_gray">D Hughes</div><div class="gs_gray">Basic &amp; Clinical Pharmacology &amp; Toxicology 109<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:s9ia6_kGH2AC" class="gsc_a_at">Involving colleagues can be challenging</a><div class="gs_gray">E Fargher, D Hughes</div><div class="gs_gray">Pharmaceutical Journal 286, 404<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:FAceZFleit8C" class="gsc_a_at">Does local testosterone therapy in adult men measure up to the 2006 Endocrine Society</a><div class="gs_gray">D Hughes, A Toogood</div><div class="gs_gray">13th European Congress of Endocrinology 26<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-f6ydRqryjwC" class="gsc_a_at">Most Effective Interventions to Improve Patient Compliance with Osteoporosis Medications</a><div class="gs_gray">M Hiligsmann, M Salas, DA Hughes, E Manias, F Gwadry-Sridhar, P Linck, ...</div><div class="gs_gray">Osteoporosis International 22 (Suppl 1), S335<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Using the Liverpool Quality of Life battery to develop a health state classification system for Epilepsy</a><div class="gs_gray">D Rowen, B Mulhern, J Brazier, A Jacoby, T Marson, N Latimer, D Snape, ...</div><div class="gs_gray">QUALITY OF LIFE RESEARCH 19, 57-57<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ufrVoPGSRksC" class="gsc_a_at">062 Abolition of prescription co-payments in Wales: an observational study on dispensing rates</a><div class="gs_gray">D Cohen, F Alam, F Dunstan, S Myles, D Hughes, P Routledge</div><div class="gs_gray">Journal of Epidemiology &amp; Community Health 64 (Suppl 1), A25-A25<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">Application of health psychology to explain adherence to medicines in adult patients: a systematic review of empirical studies</a><div class="gs_gray">E Fargher, D Hughes, T Ruppar, V Morrison</div><div class="gs_gray">PSYCHOLOGY &amp; HEALTH 25, 209-210<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">PCV21 A BENEFIT-RISK ASSESSMENT OF USING CYP2C19 GENOTYPE INFORMATION TO GUIDE ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME</a><div class="gs_gray">GF Guzauskas, D Veenstra, D Hughes</div><div class="gs_gray">Value in Health 13 (3), A152-A153<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">INTERVENTIONS TO IMPROVE COMPLIANCE WITH LIPID LOWERING MEDICATIONS: A SYSTEMATIC REVIEW OF THE LITERATURE</a><div class="gs_gray">A Zuluaga, M Salas, F Gwadry-Sridhar, E Manias, D Hughes</div><div class="gs_gray">Value in Health, A168-A168<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:p__nRnzSRKYC" class="gsc_a_at">Translation Section</a><div class="gs_gray">A Johnston, P Stafylas, GS Stergiou, MG Duerden, DA Hughes</div><div class="gs_gray">Br J Clin Pharmacol 70 (3/460), 466<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:tKAzc9rXhukC" class="gsc_a_at">PMS49 TRENDS IN THE PRESCRIBING OF CONVENTIONAL ANTIRHEUMATIC THERAPY AMONG CANADIANS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT STUDY</a><div class="gs_gray">DL Gomez-Galicia, A Kezouh, M Salas, F Gwadry-Sridhar, E Manias, ...</div><div class="gs_gray">Value in Health 3 (13), A131<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Enhancing methodical approaches for studying bilingualism in healthcare communication: report of a trial feasibility study.</a><div class="gs_gray">GW Roberts, D Hughes, G Roberts, H Owen, L Hughes, R Whitaker, ...</div><div class="gs_gray">International Conference on Communication in Healthcare (EACH), Verona, Italy.<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Evidence-based delivery</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">Pharmacy in Public Health, 101<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">PM2 IMPACT OF PHARMACOGENETICS ON THE COSTS OF MANAGING ADVERSE EVENTS WITH WARFARIN: A PROSPECTIVE ANALYSIS</a><div class="gs_gray">DA Hughes, S Al-Zubiedi, A Hanson, A Jorgensen, M Pirmohamed</div><div class="gs_gray">Value in Health 12 (3), A3-A4<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:NhqRSupF_l8C" class="gsc_a_at">CO3 ESTIMATING DRUG COSTS IN ECONOMIC EVALUATIONS IN IRELAND AND THE UK: AN ANALYSIS OF PRACTICE AND RESEARCH RECOMMENDATIONS</a><div class="gs_gray">DA Hughes, L Tilson, MF Drummond</div><div class="gs_gray">Value in Health 12 (3), A6-A7<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Folate Augmentation of Treatment-Evaluation for Depression (FolATED): protocol of a randomised controlled trial (vol 7, pg 65, 2008)</a><div class="gs_gray">SH Roberts, E Bedson, DA Hughes, KR Lloyd, DB Menkes, SJ Moat, ...</div><div class="gs_gray">BMC PSYCHIATRY 9<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:65Yg0jNCQDAC" class="gsc_a_at">Secondary ovarian failure in a patient with prolonged anorexia</a><div class="gs_gray">A Kennedy, L Shepherd, D Hughes, A Rahim, A Bates, S Bellary</div><div class="gs_gray">Society for Endocrinology BES 2009 19<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:TaaCk18tZOkC" class="gsc_a_at">Drug evaluation and pharmocoeconomics.</a><div class="gs_gray">D Hughes, J Krska, DA Hughes, AJ Winfield, JA Rees, I Smith</div><div class="gs_gray">Pharmaceutical Practice: 4th Edition., 185-198<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LK8CI43ZvvMC" class="gsc_a_at">PILSen: Practice Interventions for Language Sensitivity: a Pilot Study to Inform the Delivery of Pharmaceutical Services in Rural North Wales.</a><div class="gs_gray">GW Roberts, G Roberts, H Owen, L Hughes, S Llewelyn, S John, ...</div><div class="gs_gray">Unknown<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:8dzOF9BpDQoC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and&nbsp;…</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:mKu_rENv82IC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:NDuN12AVoxsC" class="gsc_a_at">Engaging with the MRC Methodology Hubs–NWHTMR.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">CRC Cymru Annual Meeting 2009, Cardiff, June 2009<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Comparisons between the medication possession ratio (MPR) and gaps measures of medication compliance: are we selling ourselves short by relying on the MPR?</a><div class="gs_gray">D Hughes, M Nichol, E Manias, DA Hughes, VF Schabert</div><div class="gs_gray">14th Annual Meeting of the International Society for Pharmacoeconomics and&nbsp;…<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Assessment, Determinants &amp; Economics of Medication Compliance &amp; Persistence Forum.</a><div class="gs_gray">D Hughes, DA Hughes, F Gwadry-Sridhar, E Manias</div><div class="gs_gray">14th Annual Meeting of the International Society for Pharmacoeconomics and&nbsp;…<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:lvd772isFD0C" class="gsc_a_at">Impact of the abolition of the prescription charge in Wales.</a><div class="gs_gray">D Hughes, DA Hughes, MF Alam, D Cohen, F Dunstan, S Groves, ...</div><div class="gs_gray">9th Congress of the European Association for Clinical Pharmacology and&nbsp;…<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:_Ybze24A_UAC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Ambrisentan (Volibris) for pulmonary arterial hypertension.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Abolition of prescription co-payments: an analysis of items dispensed in Wales [Abstracts]</a><div class="gs_gray">DA Hughes, F Alam, D Cohen, FDJ Dunstan, S Groves, PA Routledge</div><div class="gs_gray">Value in Health 12 (3), A80<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Maraviroc (Celsentri) for treatment-experienced adults infected only with CCR5-tropic HIV-1.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:maZDTaKrznsC" class="gsc_a_at">The economics of evergreening.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Welsh Health Economics Group, Swansea, November 2009<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:dhFuZR0502QC" class="gsc_a_at">PGI11 ECONOMIC EVALUATION OF INFLIXIMAB AND ADALIMUMAB FOR CROHN'S DISEASE</a><div class="gs_gray">DA Hughes, T Kikuchi, K Bodger</div><div class="gs_gray">Value in Health 3 (12), A59<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:6yz0xqPARnAC" class="gsc_a_at">The all wales medicines strategy group: assessments and appraisals</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">ESRC Economics Evaluation of Pharmacy Practice Seminar Series 2008/2009&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Methodological issues in the literature on costs of non-compliance in chronic diseases</a><div class="gs_gray">D Hughes, M Salas, A Zuluaga, DA Hughes, W Cowell, M Lebmeie, ...</div><div class="gs_gray">11th Annual European Congress of the International Society for&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">A SYSTEMATIC REVIEW OF THE EFFECTIVENESS OF PUBLIC HEALTH INTERVENTIONS AIMED AT PROMOTING MENTAL WELL-BEING IN OLDER PEOPLE</a><div class="gs_gray">G Windle, I Russell, P Linck, R Woods, D Hughes</div><div class="gs_gray">GERONTOLOGIST 48, 740-740<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Economic considerations for pharmacogenetic testing</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Symposium on personalised medicines. Bionow showcase conference, Liverpool, UK<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Costs of non-compliance to antipsychotic medications among patients with schizophrenia.</a><div class="gs_gray">D Hughes, DA Hughes, M Salas, A Zuluaga, W Cowell, M Lebmeier, ...</div><div class="gs_gray">13th Annual International Society for Pharmaceconomics and Outcomes Research&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.</a><div class="gs_gray">D Hughes, DA Hughes, K Bodger, T Kikuchi</div><div class="gs_gray">Welsh Health Economics Group, Swansea University, Wales, UK<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:-jrNzM816MMC" class="gsc_a_at">Statistical Comments Are Unfounded</a><div class="gs_gray">D Hughes, W Cowell, T Koncz, J Cramer</div><div class="gs_gray">Value in Health 11 (2), 346-346<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:0izLItjtcgwC" class="gsc_a_at">The cost-effectiveness of biological therapies for Crohn's disease: Markov cohort analyses incorporating UK patient-level cost data</a><div class="gs_gray">D Hughes, K Bodger, T Kikuchi, DA Hughes</div><div class="gs_gray">British Society of Gastroenterology Annual Scientific Meeting, Birmingham, UK<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Economic considerations for market access of new health technologies: A case study of pharmacogenetic testing</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Centre for Prospective Regulation, University of York, UK<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">From efficacy to cost-effectiveness: Impact of patient compliance</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Department of Economics, National University of Ireland, Galway, IRE<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:s85pQhAUCrAC" class="gsc_a_at">Development of an economic model to evaluate the cost-effectiveness of rival therapies for treating Crohn’s disease.</a><div class="gs_gray">D Hughes, T Kikuchi, K Bodger, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:EsEWqaRxkBgC" class="gsc_a_at">Public health interventions to promote well-being in people aged 65 and over: systematic review of effectiveness and cost-effectiveness: Evidence Tables.</a><div class="gs_gray">D Hughes, PG Linck, G Windle, P Linck, R Morgan, DA Hughes, V Burholt, ...</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:__bU50VfleQC" class="gsc_a_at">Charitable contributions to funding cancer services for children and young people in England and Wales</a><div class="gs_gray">D Hughes, P Linck, B Tunnage, DA Hughes, RT Edwards</div><div class="gs_gray">Journal of Child Health Care 12 (2), 156-168<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:U_HPUtbDl20C" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Topotecan (Hycamtin®) for Small Cell Lung Carcinoma.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:q-HalDI95KYC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Icatibant (Firazyr) for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults (with C1&nbsp;…</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">Charitable contributions to funding cancer services for children and young people in England and Wales</a><div class="gs_gray">P Linck, B Tunnage, D Hughes, RT Edwards</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:PaBasH6fAo0C" class="gsc_a_at">Chiral chromatography: Costs of chiral switching.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Pharmaceutical Journal 281, 213<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Docetaxel (Taxotere) for locally advanced squamous cell carcinoma of the head and neck.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Erratum to “A global survey of antibiotic leftovers in the outpatient setting”[International Journal of Antimicrobial Agents 30 (2007) 530–536]</a><div class="gs_gray">P Kardas, JC Pechère, DA Hughes, G Cornaglia</div><div class="gs_gray">International Journal of Antimicrobial Agents 2 (31), 188<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Tenofovir disoproxil fumarate (Viread) for the treatment of hepatitis B.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HeT0ZceujKMC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Pegfilgrastim (Neulasta) for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in&nbsp;…</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Lenalidomide (Revlimid) for multiple myeloma.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">PMH52 COSTS OF NON-COMPLIANCE WITH ANTIPSYCHOTIC MEDICATIONS AMONG PATIENTS WITH SCHIZOPHRENIA</a><div class="gs_gray">M Salas, A Zuluaga, D Hughes, M Lebmeier, K Vardeva, M Pisu, ...</div><div class="gs_gray">Value in Health 3 (11), A125<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Public health interventions to promote well-being in people aged 65 and over: systematic review of effectiveness and cost-effectiveness: Evidence Tables.</a><div class="gs_gray">G Windle, P Linck, R Morgan, DA Hughes, V Burholt, C Reeves, ST Yeo, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Fondaparinux Sodium (Arixtra®) for STEMI.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:XoXfffV-tXoC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human&nbsp;…</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Trabectedin (Yondelis) for advanced soft tissue sarcoma.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Teriparatide (Forsteo) for the treatment of osteoporosis in men at increased risk of fracture.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:M7yex6snE4oC" class="gsc_a_at">Effects of the abolition of prescription charges in Wales: a preliminary analysis.</a><div class="gs_gray">D Hughes, D Cohen, MF Alam, DA Hughes, F Dunstan, P Routledge</div><div class="gs_gray">International Journal of Pharmacy Practice 16 (Supplement 1), A39<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:epqYDVWIO7EC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Buprenorphine/naloxone (Suboxone) as substitution treatment for opioid dependence.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:EkHepimYqZsC" class="gsc_a_at">942 The Cost-Effectiveness of Biological Therapies for Crohn's Disease: Markov Cohort Analyses Incorporating UK Patient-Level Cost Data</a><div class="gs_gray">K Bodger, T Kikuchi, DA Hughes</div><div class="gs_gray">Gastroenterology 4 (134), A-139-A-140<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Development of an economic model to evaluate the cost-effectiveness of rival therapies for treating Crohn s disease.</a><div class="gs_gray">T Kikuchi, K Bodger, DA Hughes</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Deferasirox (Exjade) for the treatment of chronic iron overload due to blood transfusions.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:1qzjygNMrQYC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine&nbsp;…</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LPZeul_q3PIC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Rufinamide (Inovelon) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS).</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Cost-effectiveness considerations in pharmacogenetics.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">European Science Foundations-Universitat de Barcelona, Conference in&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Integrating compliance and persistence in health economics models</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Pfizer Pharmaceuticals, Sanwdwich, Kent, UK<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:blknAaTinKkC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Raltegravir (Isentress) in combination with other antiretroviral medicinal products for the treatment of human&nbsp;…</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Stiripentol (Diacomit) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy&nbsp;…</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Evidence Tables: Public health interventions to promote mental well-being in people aged 65 and over. A systematic review of effectiveness and cost effectiveness.</a><div class="gs_gray">G Windle, P Linck, R Morgan, DA Hughes, V Burholt, C Reeves, ST Yeo, ...</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Epoetin delta (Dynepo)</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:_AeoHAGD03cC" class="gsc_a_at">The pharmacokinetic profile of Warfarn: a systematic review</a><div class="gs_gray">D Hughes, S Al-Zubiedi, DA Hughes, M Pirmohamed</div><div class="gs_gray">British Pharmacological Society winter meeting, Brighton, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ce2CqMG-AY4C" class="gsc_a_at">The pharmacokinetic profile of Warfarn: a systematic review</a><div class="gs_gray">S Al-Zubiedi, DA Hughes, M Pirmohamed</div><div class="gs_gray">British Pharmacological Society winter meeting, Brighton, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:MLfJN-KU85MC" class="gsc_a_at">Public meetings of the NICE appraisals committee</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">NICE Appraisals Committee Away Day, Manchester, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LhH-TYMQEocC" class="gsc_a_at">Orphan drug treatments: economic considerations</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Wales Gene Park, Cardiff University, Cardiff, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:5awf1xo2G04C" class="gsc_a_at">Population pharmacokinetics of warfarin: Intermin analysis of the Liverpool pharmacogenetic prospective cohort study</a><div class="gs_gray">D Hughes, I Matthews, L Aarons, S Al-Zubiedi, E Hatch, S Lane, ...</div><div class="gs_gray">Pharmacokinetics UK, Edinburgh, Scotland, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">LITERATURE REVIEW ON THE COSTS OF NON-COMPLIANCE IN OSTEOPOROSIS: POS5</a><div class="gs_gray">W Cowell, K Palmer, D Hughes</div><div class="gs_gray">Value in Health 10 (6)<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Pharmacoeconomic evaluations in Ireland, Scotland and Wales: A Celtic perspective on pharmaceutical assessment</a><div class="gs_gray">D Hughes, DA Hughes, M Drummond, K Tolley, M Ryan</div><div class="gs_gray">10th Annual European Congress of the International Society for&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">The assessment, determinants &amp; economics of medication compliance &amp; persistence</a><div class="gs_gray">D Hughes, DA Hughes, FG Sridhar, R Elliott</div><div class="gs_gray">10th Annual European Congress of the International Society for&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Interventions that enhance medication compliance and persistence: Theoretical grounding, and economic assessment</a><div class="gs_gray">D Hughes, DA Hughes, FG Sridhar, R Elliott, W Cowell</div><div class="gs_gray">10th Annual European Congress of the International Society for&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Impact of the abolition of prescription charges in Wales: a multi-level modelling approach with application to time series dispensed rate data</a><div class="gs_gray">D Hughes, F Alam, S Myles, DA Hughes, F Dunstan, P Routledge, ...</div><div class="gs_gray">Health Economics Study Group Meeting, Brunel University, London, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:W5xh706n7nkC" class="gsc_a_at">Cost of non-compliance and non-persistence with medications for diabetes mellitus</a><div class="gs_gray">D Hughes, M Salas, DA Hughes, M Lebmeier, K Vardeva</div><div class="gs_gray">23rd International Conference on Pharmacoepidemiology &amp; Therapeutic Risk&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Adverse drug reactions in economic evaluations</a><div class="gs_gray">D Hughes</div><div class="gs_gray">iHEA 2007 6th World Congress: Explorations in Health Economics Paper<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Adherence with HAART: pharmacoeconomic considerations</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">1st European Conference on HAART Adherence, Lisbon, Portugal<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:YB4bud6kWLwC" class="gsc_a_at">A parenting programme for children at risk of developing conduct disorder: A cost-effectiveness analysis</a><div class="gs_gray">D Hughes, RT Edwards, A Ceilleachair, T Bywater, DA Hughes, ...</div><div class="gs_gray">AWARD conference, Bangor University, Wales, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">What determines which interventions improve compliance, and do they improve health outcomes in a cost-effective manner?</a><div class="gs_gray">D Hughes, DA Hughes, M Salas, J Shinogle</div><div class="gs_gray">12th Annual International Society for Pharmacoeconomics and Outcomes&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Quantitative risk-benefit analysis</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">The Clinical Pharmacology Colloquium, Cardiff, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Adverse drug reactions: analysis by regulatory authorities and by economists</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Welsh Health Economics Group, Cardiff, Wales, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:JTqpx9DYBaYC" class="gsc_a_at">Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">AWARD Conference, Bangor University, Wales, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">Assessing the association between compliance and therapeutic failure for antiretroviral drugs in HIV positive patients</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">AWARD Conference, Bangor University, Wales, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">Systematic review of follow-up of cancer in primary care verses secondary care: findings for breast and lung cancer</a><div class="gs_gray">D Hughes, R Lewis, RD Neal, B France, NH Williams, C Wilkinson, ...</div><div class="gs_gray">AWARD Conference, Bangor University, Wales, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:fFSKOagxvKUC" class="gsc_a_at">Economic evaluation of steroid injections (methylprednisolone) in the treatment of Morton's neuroma: patient-blind randomised trial</a><div class="gs_gray">D Hughes, C Thomson, I Beggs, D Martin, D McCaldin, D Russell, ...</div><div class="gs_gray">AWARD Conference, Bangor University, Wales, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Falls and hip-fractures: A cost-effectiveness analysis of risk assessment and interventions for community-dwelling older people</a><div class="gs_gray">D Hughes, D Gwynne, DA Hughes, RT Edwards</div><div class="gs_gray">AWARD Conference, Bangor University, Wales, UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:zUl2_INMlC4C" class="gsc_a_at">Public health interventions to promote mental well-being in people aged 65 and over: systematic review of effectiveness and cost-effectiveness.</a><div class="gs_gray">D Hughes, G Windle, DA Hughes, P Linck, R Morgan, V Burholt, ...</div><div class="gs_gray">Unknown<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:4aZ_i-5WJEQC" class="gsc_a_at">All Wales Medicines Strategy Group Final Assessment Report–Agalsidase alfa (Replagal)</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ZqE1mSdD_DYC" class="gsc_a_at">Follow-up of cancer patients in primary care versus secondary care: systematic review.</a><div class="gs_gray">D Hughes, R Lewis, R Neal, N Williams, B France, C Wilkinson, M Hendry, ...</div><div class="gs_gray">Unknown<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:SnGPuo6Feq8C" class="gsc_a_at">Factors influencing user choices to visit either general practitioners or community pharmacists for minor ailments–a discrete choice experiment</a><div class="gs_gray">D Hughes, DA Hughes, S Myles, M Longo, C Lisles, K Hood</div><div class="gs_gray">Value in Health 10 (3), A23<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:OBSaB-F7qqsC" class="gsc_a_at">Follow-up of cancer patients in primary care versus secondary care: systematic review.</a><div class="gs_gray">R Lewis, R Neal, N Williams, B France, C Wilkinson, M Hendry, D Russell, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:otzGkya1bYkC" class="gsc_a_at">The effect of compliance upon clinical effectiveness of chlorproguanil-dapsone (CD) and artemether-lumefantrine (AL) when compared to sulfadoxine-pyrimethamine (SP) for the&nbsp;…</a><div class="gs_gray">DJ Bell, D Wootton, M Mukaka, J Montgomery, N Kayange, P Chimpeni, ...</div><div class="gs_gray">American Journal of Tropical Medicine and Hygiene 77 (5), 287-287<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:0CzhzZyukY4C" class="gsc_a_at">AWMSG criteria for appraising new medicines.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report-Emtricitabine/tenofovir DF (Truvada)</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:D_sINldO8mEC" class="gsc_a_at">Policy on ultra-orphan drugs.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:8AbLer7MMksC" class="gsc_a_at">POS5 LITERATURE REVIEW ON THE COSTS OF NON-COMPLIANCE IN OSTEOPOROSIS</a><div class="gs_gray">W Cowell, K Palmer, D Hughes</div><div class="gs_gray">Value in Health 6 (10), A394-A395<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report–Dasatinib (Sprycel®) Lymphoid blast CML and PH+ ALL.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report–Emtricitabine (Emtriva)</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">All Wales Medicines Strategy Group Final Appraisal Report–Tipranavir (Aptivus).</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:LI9QrySNdTsC" class="gsc_a_at">Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost?</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">10th European Sympoisum on Patient Compliance and Persistence, Bonn, Germany<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Clinical and econnomic importance of completion of therapy in the treatment of LRTIs</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">16th European Respiratory Society Annual Congress, Munich, Germany<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:DrR-2ekChdkC" class="gsc_a_at">Prescription fee exemption research study</a><div class="gs_gray">D Hughes, S Myles, DA Hughes, P Routledge, DF Wales</div><div class="gs_gray">AWARD/CHIRAL Conference, Swansea University, Wales, UK<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Back to basics: what is the relationship between dose and duration of drug action?</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">South West Clinical Pharmacology Group, University of Birmingham, UK<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:AHdEip9mkN0C" class="gsc_a_at">Health and economic outcomes: Why compliance matters</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">16th European Congress of Clinical Microbiology and Infectious Diseases&nbsp;…<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Physchiatrist prescribing preferences and attitudes toward promotion</a><div class="gs_gray">D Hughes, D Menkes, R Davies, DA Hughes</div><div class="gs_gray">Inaugural Conference on Disease Mongering, Newcastle, Australia<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:wvYxNZNCP7wC" class="gsc_a_at">Eliciting patients' preferences using a discrete choice experiment questionnaire: the role played by qualitative data in questionnaire design</a><div class="gs_gray">D Hughes, M Longo, DA Hughes, S Myles, C Lisles</div><div class="gs_gray">SW SAPC Annual Scientific Meeting, Birmingham, UK<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">Improving Outcomes for People with Skin Tumours including Melanoma: Analysis of the Potential Economic Impact of the Guidance.</a><div class="gs_gray">P Linck, DA Hughes, RT Edwards</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:nqdriD65xNoC" class="gsc_a_at">Comments on NICE do not reflect expertise within the profession.</a><div class="gs_gray">D Hughes, RA Elliott, K Payne</div><div class="gs_gray">The Pharmaceutical Journal 277<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:t-hv7AR41mYC" class="gsc_a_at">Improving Outcomes for People with Sarcoma: Analysis of the Potential Economic Impact of the Guidance.</a><div class="gs_gray">D Hughes, P Linck, DA Hughes, RT Edwards</div><div class="gs_gray">Unknown<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Dear Readers As the year draws to an end, we would like to thank you for your continued interest in Disease Management &amp; Health Outcomes. We hope that you have found the&nbsp;…</a><div class="gs_gray">C Alexander, A Johannessen, JG Anderson, DP Johns, J Angst, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:YohjEiUPhakC" class="gsc_a_at">Improving Outcomes for People with Sarcoma: Analysis of the Potential Economic Impact of the Guidance.</a><div class="gs_gray">P Linck, DA Hughes, RT Edwards</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Analysis of the Potential Economic Impact of Guidance of improving Outcomes for Patients with Skin Cancer</a><div class="gs_gray">P Linck, DA Hughes, RT Edwards</div><div class="gs_gray">Unknown<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:jFemdcug13IC" class="gsc_a_at">Incorporating measures of compliance and persistence in pharmacoeconomic evaluations</a><div class="gs_gray">D Hughes, DA Hughes, W Cowell</div><div class="gs_gray">International Society for Pharmacoeconomics and Outcomes Research, Florence&nbsp;…<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">Trends in and influences on use of antidiabetic drugs in primary care in the United Kingdom, 1992–2003</a><div class="gs_gray">T Walley, T Walley, D Hughes, H Kendall</div><div class="gs_gray">European Journal of Public Health 15, 95-95<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">PHP39 PUBLIC FUNDING OF DRUGS FOR ORPHAN DISEASES</a><div class="gs_gray">D Hughes</div><div class="gs_gray">Value in Health 8 (6), A192-A193<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Improving Outcomes in Children and Young People with Cancer: Analysis of the Potential Economic Impact of the Guidance.</a><div class="gs_gray">PG Linck, P Linck, B Tunnage, DA Hughes, RT Edwards</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations</a><div class="gs_gray">DA Hughes</div><div class="gs_gray">European Journal of Cancer 41 (11), 1655<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Empirical analysis of the relationship between dose and duration of drug action</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">7th Congress of the European Association of Clinical Pharmacology and&nbsp;…<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Pharmacokinetics, patient compliance and pharmaeconomics</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">7th Congress of the European Association of Clinical Pharmacology and&nbsp;…<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HIFyuExEbWQC" class="gsc_a_at">Natural history of non-functioning pituitary adenomas managed conservatively at a single neuroendocrine unit</a><div class="gs_gray">D Hughes, D Sinclair, J Holland, A Heald, L Ciin</div><div class="gs_gray">Endocrine Abstracts 9<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:KWzIFqRkAKkC" class="gsc_a_at">Improving Outcomes in Children and Young People with Cancer: Analysis of the Potential Economic Impact of the Guidance.</a><div class="gs_gray">D Hughes, P Linck, B Tunnage, DA Hughes, RT Edwards</div><div class="gs_gray">Unknown<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:NMlhSUseqAsC" class="gsc_a_at">Welsh Health Economics Network (WHEN): Scoping Report.</a><div class="gs_gray">D Hughes, A Farr, AO Ceilleachair, D Cohen, DA Hughes, C Phillips</div><div class="gs_gray">Unknown<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:zdjWy_NXXwUC" class="gsc_a_at">Welsh Health Economics Network (when)</a><div class="gs_gray">A Farr, AO Ceilleachair, D Cohen, D Hughes, C Phillips</div><div class="gs_gray">Swansea University, College of Human and Health Sciences<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:owLR8QvbtFgC" class="gsc_a_at">Welsh Health Economics Network (WHEN): Scoping Report.</a><div class="gs_gray">A Farr, A O Ceilleachair, D Cohen, DA Hughes, C Phillips</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">Internationalisation of cost-effectiveness model for on-demand use of proton pump inhibitors-Sweden.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:QVtou7C4vgoC" class="gsc_a_at">Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Value in Health 7 (6), 753<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">HLA-B* 5701 and abacavir hypersensitivity-Reply.</a><div class="gs_gray">D Hughes, DA Hughes, BK Park, M Pirmohamed</div><div class="gs_gray">Pharmacogenetics 14 (11), 784<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">From efficacy to effectiveness and cost-effectiveness: modelling possibilities</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">MRC Biostatistics Unit, University of Cambridge, UK<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">A single centre open phase IV study to evaluate the safety and tolerability of chlorproguanil-dapsone when dosed by defined height bands</a><div class="gs_gray">D Hughes, M Makanga, P Winstanley, DA Hughes</div><div class="gs_gray">American Society of Tropical Medicine and Hygiene, Miami, USA<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:5nxA0vEk-isC" class="gsc_a_at">PGI1 ECONOMIC EVALUATION OF ON-DEMAND MAINTENANCE THERAPY WITH PROTON PUMP INHIBITORS IN PATIENTS WITH SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE—A MONTE-CARLO ANALYSIS FOR ITALY</a><div class="gs_gray">DA Hughes, M Marchetti, GL Colombo</div><div class="gs_gray">Value in Health 7 (6), 753-754<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:c59VksA5Vz4C" class="gsc_a_at">Economic evaluation of on-demand maintenance therapy with proton pump inhibitors in patients with symptomatic gastroesophageal reflux disease-a Monte-Carlo analysis for Italy</a><div class="gs_gray">D Hughes, DA Hughes, M Marchetti, G Colombo</div><div class="gs_gray">International Society for Pharmacoeconomics and Outcomes Research, Hamburg&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:KUbvn5osdkgC" class="gsc_a_at">Introduction to pharmaeconomics</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Nuffield Trust-sponsored event on Pharmaceconomics in Wales, Bodelwyddan&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Pharmacoeconomics appraisals by the all Wales medicines strategy group</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Nuffield Trust-sponsored event on Pharmaceconomics in Wales, Bodelwyddan&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Pharmacoeconomic models that incorporate non-compliance</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">International Society for Pharmaceconomics and Outcomes Research, Washington&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Patient compliance and persistence with prescribed medication: Measurement and health economic impact</a><div class="gs_gray">D Hughes, T Koncz, DA Hughes, I Cleemput, L Annemans</div><div class="gs_gray">International Society for Pharmacoeconomics and Outcomes Research&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:URolC5Kub84C" class="gsc_a_at">Pharmacoeconomics of pharmacogenetic testing: azathioprine</a><div class="gs_gray">D Hughes, R McAllister, DA Hughes</div><div class="gs_gray">Economics of Genetics workshop, Christ Church Oxford, UK<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:evX43VCCuoAC" class="gsc_a_at">Pharmacoeconomics in Wales: functions of the all Wales medicines strategy group</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Welsh Health Economics Group, Llandudno, Wales, UK<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:KxtntwgDAa4C" class="gsc_a_at">The pituitary lesion that escaped the knife</a><div class="gs_gray">A Heald, D Hughes, H Buckler</div><div class="gs_gray">23rd Joint Meeting of the British Endocrine Societies with the European&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Modelling in health economics</a><div class="gs_gray">D Hughes, DA Hughes, T Walley, A Haycox, A Boland, A Breckenridge</div><div class="gs_gray">Pharmacoeconomics, 141-154<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Internationalisation of cost-effectiveness model for on-demand use of proton pump inhibitors-Belgium.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Approaches to pharmacoeconomic analysis</a><div class="gs_gray">D Hughes, DA Hughes, T Walley, A Haycox, A Boland, A Breckenridge</div><div class="gs_gray">Pharmacoeconomics, 101-126<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:0EnyYjriUFMC" class="gsc_a_at">The future challenges</a><div class="gs_gray">D Hughes, DA Hughes, T Walley, A Haycox, A Boland, A Breckenridge</div><div class="gs_gray">Pharmacoeconomics, 167-174<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:zCSUwVk65WsC" class="gsc_a_at">Drug compliance and pharmaceconomics</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Institute of Medical and Social Care Research, University of Bangor, Wales, UK<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">Use of PK-PD modelling to predict the impact of non-compliance</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">South West Clinical Pharmacology Group, Liverpool, UK<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">PIN11 ABACAVIR HYPERSENSITIVITY: IS PREPRESCRIPTION GENOTYPING COSTEFFECTIVE?</a><div class="gs_gray">DA Hughes, M Pirmohamed</div><div class="gs_gray">Value in Health 6 (6), 749<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:yFnVuubrUp4C" class="gsc_a_at">Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">International Society for Pharmacoeconomics and Outcomes Research, Barcelona&nbsp;…<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Cost-utility analysis of on demand rabeprazole and esomeprazole for symptomatic gastro oesophageal reflux disease</a><div class="gs_gray">D Hughes, DA Hughes, D Dubois</div><div class="gs_gray">Value in Health 6 (6), 613<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Modelling changes in first line antimalarial therapy</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Wellcome Trust Centre for Research in Clinical Tropical Medicines, Annual&nbsp;…<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">The population pharmacokinetics of lapdap</a><div class="gs_gray">D Hughes, S Ward, J Simpson, L Aarons, S Szwandt, DA Hughes</div><div class="gs_gray">3rd MIM pan-African malaria conference, Arusha, Tanzania, Africa<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Accurate and practical dosing of African populations using a height, weight and age model designed for lapdap</a><div class="gs_gray">D Hughes, DA Hughes, A Bagust</div><div class="gs_gray">3rd MIM pan-African malaria conference, Arusha, Tanzania, Africa<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Economic evaluation during early (phase II) trials</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Pharmaworks, London, UK<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Patient compliance and pharmacoeconomics</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Health Economics Research Group, Brunel University, UK<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Impact of non-compliance on the cost-effectiveness of pharmaceuticals</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:mB3voiENLucC" class="gsc_a_at">From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">International Society for Pharmacoeconomics and Outcomes Reesearch&nbsp;…<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:35r97b3x0nAC" class="gsc_a_at">Impact of non-compliance on the therapeutic coverage of oxybutynin–comparison of once-and twice-daily oral formulations.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Impact of non-compliance on the therapeutic coverage of risperidone–comparison of long acting injectible with oral formulations.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Impact of non-compliance on the clinical and cost-effectiveness of statins</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">International Society for Pharmacoeconomics and Outcomes Research, Cannes&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Pharmacometric analysis of duration of drug action: implications for improved forgiveness to medication non-compliance</a><div class="gs_gray">D Hughes, DA Hughes, T Walley</div><div class="gs_gray">Congress of the European Association for Clinical Pharmacology and&nbsp;…<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">A review of economic models for second-line chemotherapy in the management of advanced, metastatic breast cancer.</a><div class="gs_gray">D Hughes, DA Hughes</div><div class="gs_gray">Unknown<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:Aul-kAQHnToC" class="gsc_a_at">Pharmacokinetic-Pharmacodynamic modelling of Lapdap (CPG-DDS) combination.</a><div class="gs_gray">D Hughes, DA Hughes, B Watkins, P Winstanley</div><div class="gs_gray">Unknown<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Pragmatic trials-design features and implications for clinical decision making</a><div class="gs_gray">D Hughes, H Urdahl, DA Hughes, N Freemantle</div><div class="gs_gray">16th International Conference on Pharmacoepidemiology, Barcelona, Spain<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:mel-f30kHHgC" class="gsc_a_at">Molecular cytogenetic analysis of 7q deletions in haematological malignancies.</a><div class="gs_gray">S Tosi, J Harbott, QA Haas, A Douglas, D Hughes, F Ross, A Biondi, ...</div><div class="gs_gray">Blood 86 (10), 2965-2965<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Commentary</a><div class="gs_gray">I Hughes</div><div class="gs_gray">Archives of Disease in Childhood 72 (4), 367-368<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:sJPMR1oEGYQC" class="gsc_a_at">Mechanistically Informed Non-Invasive Peripheral Nerve Stimulation for Peripheral Neuropathic Pain: A Randomised Double-Blind Sham-Controlled Trial</a><div class="gs_gray">S Johnson, A Marshall, D Hughes, E Holmes, F Henrich, T Nurmiko, ...</div><div class="gs_gray">Available at SSRN 3889344<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:isU91gLudPYC" class="gsc_a_at">Individual responses</a><div class="gs_gray">D Hughes</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:YsrPvlHIBpEC" class="gsc_a_at">Our thanks to all those who have helped with this issue of Pharmacogenomics. Listed below are authors, referees and others who have kindly given their time, effort and&nbsp;…</a><div class="gs_gray">R Berecz, M Boisdron-Celle, M Bosia, G Burckart, KA Charles, SJ Clarke, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Please select your preffered valuta to pay</a><div class="gs_gray">A Fuchs</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">THEMED SECTION: RARE DISEASES Editorial 491 Rare Diseases: Addressing the Challenges in Diagnosis, Drug Approval, and Patient Access</a><div class="gs_gray">K Copley-Merriman, S Nestler-Parr, D Korchagina, M Toumi, CL Pashos, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">The Most Effective Patient Adherence Interventions of Lipid Lowering Medications-A Systematic Review of the Literature: A Report of the ISPOR Medication Adherence and&nbsp;…</a><div class="gs_gray">M Salas, S Glasser, DA Hughes, FHGSBS Pharm, E Manias, ...</div><div class="gs_gray">therapy 4, 5<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">Parenting programme for parents of children at</a><div class="gs_gray">J Hutchings, RT Edwards, A Céilleachair, T Bywater, DA Hughes</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Analysis of the Potential Economic Impact of the Guidance:‘Improving Outcomes for people with Sarcoma’</a><div class="gs_gray">P Linck, DA Hughes, RT Edwards</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Our thanks to all those who have helped with this issue of Pharmacogenomics. Listed below are authors, referees and others who have kindly given their time, effort and&nbsp;…</a><div class="gs_gray">A Agrawal, S Bayat, D Brazeau, WL Chang, A Chatzimichael, MH Chiou, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:dshw04ExmUIC" class="gsc_a_at">Understanding medication compliance and persistence from an economics perspective</a><div class="gs_gray">M Bhosle, DA Hughes</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=_q2u5IIAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=_q2u5IIAAAAJ:_xSYboBqXhAC" class="gsc_a_at">L12 2AP Tel:+ 44 151 252 5281 Email: jo. blair@ alderhey. nhs. uk</a><div class="gs_gray">J Blair, JW Gregory, D Hughes, C Ridyard, C Gamble, A McKay, M Didi, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–548</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>